[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[S. 1860 Introduced in Senate (IS)]







108th CONGRESS
  1st Session
                                S. 1860

       To reauthorize the Office of National Drug Control Policy.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

            November 14 (legislative day, November 12), 2003

  Mr. Hatch (for himself, Mr. Biden, and Mr. Grassley) introduced the 
 following bill; which was read twice and referred to the Committee on 
                             the Judiciary

_______________________________________________________________________

                                 A BILL


 
       To reauthorize the Office of National Drug Control Policy.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE, REFERENCE, AND TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``Office of National 
Drug Control Policy Reauthorization Act of 2003''.
    (b) Amendment of Office of National Drug Control Policy 
Reauthorization Act of 1998.--Except as otherwise expressly provided, 
whenever in this Act an amendment or repeal is expressed in terms of an 
amendment to, or repeal of, a section or other provision, the reference 
shall be considered to be made to a section or other provision of the 
Office of National Drug Control Policy Reauthorization Act of 1998 
(Public Law 105-277; 21 U.S.C. 1701 et seq.).
    (c) Table of Contents.--The table of contents for this Act is as 
follows:

Sec. 1. Short title, reference, and table of contents.
  TITLE I--ORGANIZATION OF OFFICE OF NATIONAL DRUG CONTROL POLICY AND 
                       ROLES AND RESPONSIBILITIES

Sec. 101. Amendments to definitions.
Sec. 102. Establishment of the Office of National Drug Control Policy.
Sec. 103. Appointment and responsibilities of the Director.
Sec. 104. Amendments to ensure coordination with other agencies.
              TITLE II--THE NATIONAL DRUG CONTROL STRATEGY

Sec. 201. Annual preparation and submission of national drug control 
                            strategy.
Sec. 202. Performance measurements.
 TITLE III--HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM AND COUNTER-
                   DRUG TECHNOLOGY ASSESSMENT CENTER

Sec. 301. Purpose of high intensity drug trafficking areas program.
Sec. 302. Designation of HIDTAs and evaluation of HIDTA performance.
Sec. 303. Organization of HIDTAs.
Sec. 304. HIDTA funding.
Sec. 305. Assessment of task forces in HIDTA areas.
Sec. 306. Funding for certain HIDTA areas.
Sec. 307. Report on intelligence sharing.
Sec. 308. Counter-Drug Technology Assessment Center.
  TITLE IV--REAUTHORIZATION AND IMPROVEMENT OF THE NATIONAL ANTI-DRUG 
                             MEDIA CAMPAIGN

Sec. 401. Short title.
Sec. 402. Purposes of the national anti-drug media campaign.
Sec. 403. Roles and responsibilities of the Director, the Partnership 
                            for a Drug-Free America, and a media buying 
                            contractor.
Sec. 404. Responsible use of Federal funds for the national anti-drug 
                            media campaign.
Sec. 405. GAO audit of national media campaign.
Sec. 406. Authorization for national media campaign.
       TITLE V--AUTHORIZATIONS AND EXTENSION OF TERMINATION DATE

Sec. 501. Authorization of appropriations.
Sec. 502. Extension of termination date.
       TITLE VI--DESIGNATION OF UNITED STATES ANTI-DOPING AGENCY

Sec. 601. Designation of United States Anti-Doping Agency.
Sec. 602. Authorization of appropriations.
          TITLE VII--DRUG EDUCATION, PREVENTION, AND TREATMENT

Sec. 701. Expansion of substance abuse education and prevention 
                            efforts.
Sec. 702. Funding for rural States and economically depressed 
                            communities.
Sec. 703. Residential treatment programs for juveniles.
Sec. 704. Drug treatment alternative to prison programs administered by 
                            State or local prosecutors.
Sec. 705. Funding for residential treatment centers for women and 
                            children.
            TITLE VIII--ANABOLIC STEROID CONTROL ACT OF 2003

Sec. 801. Short title.
Sec. 802. Amendments to the Controlled Substances Act.
Sec. 803. Sentencing Commission guidelines.
Sec. 804. Prevention and education programs.
Sec. 805. National survey on drug use and health.
             TITLE IX--NATIONAL GUARD COUNTER-DRUG SCHOOLS

Sec. 901. National Guard counter-drug schools.
                   TITLE X--MISCELLANEOUS PROVISIONS

Sec. 1001. Repeals.
Sec. 1002. Amendment to the Higher Education Act of 1965.
Sec. 1003. Controlled Substances Act amendment.
Sec. 1004. Exportation of narcotic and nonnarcotic drugs.
Sec. 1005. Study of work place environment at ONDCP.
Sec. 1006. Requirement for Latin American heroin strategy.

  TITLE I--ORGANIZATION OF OFFICE OF NATIONAL DRUG CONTROL POLICY AND 
                       ROLES AND RESPONSIBILITIES

SEC. 101. AMENDMENTS TO DEFINITIONS.

    (a) Demand Reduction.--Section 702(1) is amended--
            (1) in subparagraph (F), by striking ``and'' after the 
        semicolon; and
            (2) in subparagraph (G), by striking the period and 
        inserting ``; and''; and
            (3) by adding at the end the following:
                    ``(H) international drug abuse education, 
                prevention, treatment, research, rehabilitation 
                activities, and interventions for drug abuse and 
                dependence.''.
    (b) Office.--Section 702(9) is amended by striking ``implicates'' 
and inserting ``indicates''.
    (c) State and Local Affairs.--Paragraph (10) of section 702 is 
amended to read as follows:
            ``(10) State and local affairs.--The term `State and local 
        affairs' means domestic activities conducted by a National Drug 
        Control Program agency that are intended to reduce the 
        availability and use of drugs, including--
                    ``(A) coordination and enhancement of Federal, 
                State, and local law enforcement drug control efforts;
                    ``(B) coordination and enhancement of efforts among 
                National Drug Control Program agencies and State and 
                local demand reduction and supply reduction agencies;
                    ``(C) coordination and enhancement of Federal, 
                State, and local law enforcement initiatives to gather, 
                analyze, and disseminate information and intelligence 
                among law enforcement agencies; and
                    ``(D) other coordinated and joint initiatives among 
                Federal, State, and local agencies to promote 
                comprehensive drug control strategies designed to 
                reduce the demand for, and the availability of, illegal 
                drugs.''.
    (d) Supply Reduction.--Section 702(11) is amended to read as 
follows:
            ``(11) Supply reduction.--The term `supply reduction' means 
        any activity of a program conducted by a National Drug Control 
        Program agency that is intended to reduce the availability or 
        use of drugs in the United States or abroad, including--
                    ``(A) activities to control international 
                trafficking in, and availability of, illegal drugs, 
                including--
                            ``(i) accurate assessment and monitoring of 
                        international drug production and interdiction 
                        programs and policies; and
                            ``(ii) coordination and promotion of 
                        compliance with international treaties relating 
                        to the production, transportation, or 
                        interdiction of illegal drugs;
                    ``(B) activities to conduct and promote 
                international law enforcement programs and policies to 
                reduce the supply of drugs; and
                    ``(C) activities to facilitate and enhance the 
                sharing of domestic and foreign intelligence 
                information among National Drug Control Program 
                agencies, relating to the production and trafficking of 
                drugs in the United States and in foreign countries.''.
    (e) Definition of Appropriate Congressional Committees.--Section 
702 is amended by adding at the end the following:
            ``(12) Appropriate congressional committees.--Except where 
        otherwise provided, the term `appropriate congressional 
        committees' means the Committee on the Judiciary, the Committee 
        on Appropriations, and the Caucus on International Narcotics 
        Control of the Senate and the Committee on Government Reform, 
        the Committee on the Judiciary, and the Committee on 
        Appropriations of the House of Representatives.''.

SEC. 102. ESTABLISHMENT OF THE OFFICE OF NATIONAL DRUG CONTROL POLICY.

    (a) Responsibilities.--Section 703(a) is amended to read as 
follows:
    ``(a) Establishment of Office.--There is established in the 
Executive Office of the President an Office of National Drug Control 
Policy, which shall--
            ``(1) develop national drug control policy;
            ``(2) coordinate and oversee the implementation of the 
        national drug control policy;
            ``(3) assess and certify the adequacy of national drug 
        control programs and the budget for those programs;
            ``(4) evaluate the effectiveness of National Drug Control 
        Program agencies' programs; and
            ``(5) develop specific goals and performance measurements 
        needed to assess the effectiveness of--
                    ``(A) the national drug control policy; and
                    ``(B) the programs of the National Drug Control 
                Program agencies.''.
    (b) Positions.--Section 703(b) is amended to read as follows:
    ``(b) Director of National Drug Control Policy and Deputy 
Directors.--
            ``(1) Director.--There shall be a Director of National Drug 
        Control Policy who shall head the Office (referred to in this 
        Act as the `Director').
            ``(2) Deputy director.--There shall be a Deputy Director of 
        National Drug Control Policy who shall report directly to the 
        Director (referred to in this Act as the `Deputy Director').
            ``(3) Other deputy directors.--
                    ``(A) In general.--There shall be a Deputy Director 
                for Demand Reduction, a Deputy Director for Supply 
                Reduction, and a Deputy Director for State and Local 
                Affairs.
                    ``(B) Reporting.--The Deputy Director for Demand 
                Reduction, the Deputy Director for Supply Reduction, 
                the Deputy Director for State and Local Affairs, and 
                the Chief Scientist shall report directly to the Deputy 
                Director of the Office of National Drug Control Policy.
                    ``(C) Deputy director for demand reduction.--The 
                Deputy Director for Demand Reduction shall be 
                responsible for the activities--
                            ``(i) in subparagraphs (A) through (H) of 
                        section 702(l); and
                            ``(ii) in section 709, the National Youth 
                        Anti-Drug Media Campaign Act.
                    ``(D) Deputy director for supply reduction.--The 
                Deputy Director for Supply Reduction shall be 
                responsible for the activities in subparagraphs (A) 
                through (C) in section 702(11).
                    ``(E) Deputy director for state and local 
                affairs.--The Deputy Director for State and Local 
                Affairs shall be responsible for the activities--
                            ``(i) in subparagraphs (A) through (D) of 
                        section 702(10); and
                            ``(ii) in section 707, the High Intensity 
                        Drug Trafficking Areas Program.''.

SEC. 103. APPOINTMENT AND RESPONSIBILITIES OF THE DIRECTOR.

    (a) Succession.--Section 704(a) is amended by amending paragraph 
(3) to read as follows:
            ``(3) Acting director.--If the Director dies, resigns, or 
        is otherwise unable to perform the functions and duties of the 
        office, the Deputy Director shall perform the functions and 
        duties of the Director temporarily in an acting capacity 
        pursuant to subchapter III of chapter 33 of title 5, United 
        States Code.''.
    (b) Responsibilities.--Section 704(b) is amended--
            (1) in paragraph (4), by striking ``Federal departments and 
        agencies engaged in drug enforcement'' and inserting ``National 
        Drug Control Program agencies'';
            (2) in paragraph (7), by inserting after ``President'' the 
        following: ``and the appropriate congressional committees'';
            (3) in paragraph (13), by striking ``(beginning in 1999)'';
            (4) by striking paragraph (14) and inserting the following:
            ``(14) shall submit to the appropriate congressional 
        committees on an annual basis, not later than 60 days after the 
        date of the last day of the applicable period, a summary of--
                    ``(A) each of the evaluations received by the 
                Director under paragraph (13); and
                    ``(B) the progress of each National Drug Control 
                Program agency toward the drug control program goals of 
                the agency using the performance measures for the 
                agency developed under section 706(d);'';
            (5) in paragraph (15), by striking subparagraph (C) and 
        inserting the following:
                    ``(C) supporting the substance abuse information 
                clearinghouse administered by the Administrator of the 
                Substance Abuse and Mental Health Services 
                Administration and established in section 501(d)(16) of 
                the Public Health Service Act by--
                            ``(i) encouraging all National Drug Control 
                        Program agencies to provide all appropriate and 
                        relevant information; and
                            ``(ii) supporting the dissemination of 
                        information to all interested entities;''; and
            (6) by inserting at the end the following:
            ``(16) shall coordinate with the private sector to promote 
        private research and development of medications to treat 
        addiction;
            ``(17) shall seek the support and commitment of State and 
        local officials in the formulation and implementation of the 
        National Drug Control Strategy;
            ``(18) shall monitor and evaluate the allocation of 
        resources among Federal law enforcement agencies in response to 
        significant local and regional drug trafficking and production 
        threats; and
            ``(19) shall submit an annual report to Congress detailing 
        how the Office of National Drug Control Policy has consulted 
        with and assisted State and local governments with respect to 
        the formulation and implementation of the National Drug Control 
        Strategy and other relevant issues.''.
    (c) Review and Certification of National Drug Control Program 
Budget.--Section 704(c)(3) is amended--
            (1) in subparagraph (C)(iii), by inserting ``and the 
        appropriate congressional committees,'' after ``House of 
        Representatives''; and
            (2) in subparagraph (D)(ii)(II)(bb), by inserting ``and the 
        appropriate congressional committees,'' after ``House of 
        Representatives''.
    (d) Powers of Director.--Section 704(d) is amended--
            (1) in paragraph (9)--
                    (A) by inserting ``notwithstanding any other 
                provision of law,'' after ``(9)''; and
                    (B) by striking ``Strategy; and'' and inserting 
                ``Strategy and notify the appropriate congressional 
                committees of any fund control notice issued in 
                accordance with section 704(f)(5);''; and
            (2) in paragraph (10), by inserting before the period the 
        following: ``and section 706 of the Department of State 
        Authorization Act for Fiscal Year 2003 (22 U.S.C. 229j-1)''.
    (e) Fund Control Notices.--Section 704(f) is amended by adding at 
the end the following:
            ``(4) Congressional notice.--A copy of each fund control 
        notice shall be transmitted to the appropriate congressional 
        committees.
            ``(5) Restrictions.--The Director shall not issue a fund 
        control notice to direct that all or part of an amount 
        appropriated to the National Drug Control Program agency 
        account be obligated, modified, or altered in any manner--
                    ``(A) contrary, in whole or in part, to a specific 
                appropriation; or
                    ``(B) contrary, in whole or in part, to the 
                expressed intent of Congress.''.
    (f) United States Interdiction Coordinator.--
            (1) In general.--Section 704 is amended by adding at the 
        end the following:
    ``(i) United States Interdiction Coordinator.--
            ``(1) In general.--There shall be a United States 
        Interdiction Coordinator, who shall be designated by the 
        Director and who shall be responsible for the coordination of 
        interdiction operations among National Drug Control Program 
        agencies to prevent and reduce the illegal importation of drugs 
        into the United States.
            ``(2) Responsibilities.--The United States Interdiction 
        Coordinator shall be responsible to the Director for--
                    ``(A) coordinating National Drug Control Program 
                agencies' interdiction activities to ensure consistency 
                with the National Drug Control Strategy;
                    ``(B) developing a National Drug Control 
                Interdiction plan consistent with the National Drug 
                Control Strategy;
                    ``(C) assessing the sufficiency of National Drug 
                Control Program agencies' assets committed to illicit 
                drug interdiction; and
                    ``(D) advising the Director on the efforts of each 
                National Drug Control Program agency to implement the 
                National Drug Control Interdiction plan.''.
            (2) Amendment to homeland security act of 2002.--Section 
        878 of the Homeland Security Act of 2002 (6 U.S.C. 458) is 
        amended by striking ``shall--'' through paragraph (2) and 
        inserting ``shall ensure the adequacy of resources within the 
        Department for illicit drug interdiction.''.

SEC. 104. AMENDMENTS TO ENSURE COORDINATION WITH OTHER AGENCIES.

    Section 705 is amended--
            (1) in subsection (a)(1)(A), by striking ``abuse'';
            (2) by amending subsection (a)(3) to read as follows:
            ``(3) Required reports.--
                    ``(A) Secretaries of the interior and 
                agriculture.--Not later than July 1 of each year, the 
                Secretaries of Agriculture and the Interior shall 
                jointly submit to the Director and the appropriate 
                congressional committees an assessment of the quantity 
                of illegal drug cultivation and manufacturing in the 
                United States on lands owned or under the jurisdiction 
                of the Federal Government for the preceding year.
                    ``(B) Secretary of homeland security.--Not later 
                than July 1 of each year, the Secretary of Homeland 
                Security shall submit to the Director and the 
                appropriate congressional committees information for 
                the preceding year regarding--
                            ``(i) the number and type of seizures of 
                        drugs by each component of the Department 
                        seizing drugs, as well as statistical 
                        information on the geographic areas of such 
                        seizures; and
                            ``(ii) the number of air and maritime 
                        patrol hours undertaken by each component of 
                        the Department primarily dedicated to drug 
                        supply reduction missions.
                    ``(C) Secretary of defense.--The Secretary of 
                Defense shall, by July 1 of each year, submit to the 
                Director and the appropriate congressional committees 
                information for the preceding year regarding the number 
                of air and maritime patrol hours primarily dedicated to 
                drug supply reduction missions undertaken by each 
                component of the Department of Defense.''; and
            (3) in subsection (b)(2)(B), by striking ``Program'' and 
        inserting ``Strategy''.

              TITLE II--THE NATIONAL DRUG CONTROL STRATEGY

SEC. 201. ANNUAL PREPARATION AND SUBMISSION OF NATIONAL DRUG CONTROL 
              STRATEGY.

    Section 706 is amended to read as follows:

``SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, AND ASSESSMENT OF 
              NATIONAL DRUG CONTROL STRATEGY.

    ``(a) Timing, Contents, and Process for Development and Submission 
of National Drug Control Strategy.--
            ``(1) Timing.--Not later than February 1st of each year, 
        the President shall submit to Congress a National Drug Control 
        Strategy, which shall set forth a comprehensive plan for the 
        year to reduce drug abuse and the consequences of such drug 
        abuse in the United States by limiting the availability of, and 
        reducing the demand for, illegal drugs.
            ``(2) Contents.--
                    ``(A) In general.--The National Drug Control 
                Strategy submitted under paragraph (1) shall include--
                            ``(i) comprehensive, research-based, long 
                        range, quantifiable goals for reducing drug 
                        abuse and the consequences of drug abuse in the 
                        United States;
                            ``(ii) annual quantifiable and measurable 
                        objectives and specific targets to accomplish 
                        long-term quantifiable goals that the Director 
                        determines may be achieved during each year 
                        beginning on the date on which the National 
                        Drug Control Strategy is submitted;
                            ``(iii) 5-year projections for program and 
                        budget priorities;
                            ``(iv) a review of international, State, 
                        local, and private sector drug control 
                        activities to ensure that the United States 
                        pursues coordinated and effective drug control 
                        at all levels of government;
                            ``(v) an assessment of current illicit drug 
                        use (including inhalants) and availability, 
                        impact of illicit drug use, and treatment 
                        availability, which assessment shall include--
                                    ``(I) estimates of drug prevalence 
                                and frequency of use as measured by 
                                national, State, and local surveys of 
                                illicit drug use and by other special 
                                studies of nondependent and dependent 
                                illicit drug use;
                                    ``(II) illicit drug use in the 
                                workplace and the productivity lost by 
                                such use; and
                                    ``(III) illicit drug use by 
                                arrestees, probationers, and parolees;
                            ``(vi) an assessment of the reduction of 
                        illicit drug availability, as measured by--
                                    ``(I) the quantities of cocaine, 
                                heroin, marijuana, methamphetamine, 
                                ecstasy, and other drugs available for 
                                consumption in the United States;
                                    ``(II) the amount of marijuana, 
                                cocaine, heroin, methamphetamine, 
                                ecstasy, and precursor chemicals and 
                                other drugs entering the United States;
                                    ``(III) the number of illicit drug 
                                manufacturing laboratories seized and 
                                destroyed and the number of hectares of 
                                marijuana, poppy, and coca cultivated 
                                and destroyed domestically and in other 
                                countries;
                                    ``(IV) the number of metric tons of 
                                marijuana, heroin, cocaine, and 
                                methamphetamine seized and other drugs; 
                                and
                                    ``(V) changes in the price and 
                                purity of heroin, methamphetamine, and 
                                cocaine, changes in the price of 
                                ecstasy, and changes in 
                                tetrahydrocannabinol level of marijuana 
                                and other drugs;
                            ``(vii) an assessment of the reduction of 
                        the consequences of illicit drug use and 
                        availability, which shall include--
                                    ``(I) the burden illicit drug users 
                                placed on hospital emergency 
                                departments in the United States, such 
                                as the quantity of illicit drug-related 
                                services provided;
                                    ``(II) the annual national health 
                                care cost of illicit drug use; and
                                    ``(III) the extent of illicit drug-
                                related crime and criminal activity;
                            ``(viii) a determination of the status of 
                        drug treatment in the United States, by 
                        assessing--
                                    ``(I) public and private treatment 
                                utilization; and
                                    ``(II) the number of illicit drug 
                                users the Director estimates meet 
                                diagnostic criteria for treatment;
                            ``(ix) a review of the research agenda of 
                        the Counter-Drug Technology Assessment Center 
                        to reduce the availability and abuse of drugs; 
                        and
                            ``(x) a summary of the efforts made to 
                        coordinate with private sector entities to 
                        conduct private research and development of 
                        medications to treat addiction by--
                                    ``(I) screening chemicals for 
                                potential therapeutic value;
                                    ``(II) developing promising 
                                compounds;
                                    ``(III) conducting clinical trials;
                                    ``(IV) seeking Food and Drug 
                                Administration approval for drugs to 
                                treat addiction;
                                    ``(V) marketing the drug for the 
                                treatment of addiction;
                                    ``(VI) urging physicians to use the 
                                drug in the treatment of addiction; and
                                    ``(VII) encouraging insurance 
                                companies to reimburse the cost of the 
                                drug for the treatment of addiction.
                    ``(B) Classified information.--Any contents of the 
                National Drug Control Strategy that involves 
information properly classified under criteria established by an 
Executive order shall be presented to Congress separately from the rest 
of the National Drug Control Strategy.
            ``(3) Process for development and submission.--In 
        developing and effectively implementing the National Drug 
        Control Strategy, the Director--
                    ``(A) shall consult with--
                            ``(i) the heads of the National Drug 
                        Control Program agencies;
                            ``(ii) Congress;
                            ``(iii) State and local officials;
                            ``(iv) private citizens and organizations 
                        with experience and expertise in demand 
                        reduction;
                            ``(v) private citizens and organizations 
                        with experience and expertise in supply 
                        reduction; and
                            ``(vi) appropriate representatives of 
                        foreign governments;
                    ``(B) in satisfying the requirements of 
                subparagraph (A), shall ensure, to the maximum extent 
                possible, that State and local officials and relevant 
                private organizations commit to support and take steps 
                to achieve the goals and objectives of the National 
                Drug Control Strategy;
                    ``(C) with the concurrence of the Attorney General, 
                may require the El Paso Intelligence Center to 
                undertake specific tasks or projects to support or 
                implement the National Drug Control Strategy; and
                    ``(D) with the concurrence of the Director of 
                Central Intelligence and the Attorney General, may 
                request that the National Drug Intelligence Center 
                undertake specific tasks or projects to support or 
                implement the National Drug Control Strategy.
    ``(b) Submission of Revised Strategy.--The President may submit to 
Congress a revised National Drug Control Strategy that meets the 
requirements of this section--
            ``(1) at any time, upon a determination of the President, 
        in consultation with the Director, that the National Drug 
        Control Strategy in effect is not sufficiently effective; or
            ``(2) if a new President or Director takes office.''.

SEC. 202. PERFORMANCE MEASUREMENTS.

    Section 706 is amended by adding at the end the following:
    ``(c) Performance Measurement System.--Not later than February 1st 
of each year, the Director shall submit to Congress as part of the 
National Drug Control Strategy, a description of a national drug 
control performance measurement system, that--
            ``(1) develops annual and 5-year performance measures and 
        targets for each National Drug Control Strategy goal and 
        objective established for reducing drug use, availability, and 
        the consequences of drug use;
            ``(2) describes the sources of information and data that 
        will be used for each performance measure incorporated into the 
        performance measurement system;
            ``(3) identifies major programs and activities of the 
        National Drug Control Program agencies that support the goals 
        and annual objectives of the National Drug Control Strategy;
            ``(4) evaluates the contribution of demand reduction and 
        supply reduction activities as defined in section 702 
        implemented by each National Drug Control Program agency in 
        support of the National Drug Control Strategy;
            ``(5) monitors consistency between the drug-related goals 
        and objectives of the National Drug Control Program agencies 
        and ensures that each agency's goals and budgets support and 
        are fully consistent with the National Drug Control Strategy; 
        and
            ``(6) coordinates the development and implementation of 
        national drug control data collection and reporting systems to 
        support policy formulation and performance measurement, 
        including an assessment of--
                    ``(A) the quality of current drug use measurement 
                instruments and techniques to measure supply reduction 
                and demand reduction activities;
                    ``(B) the adequacy of the coverage of existing 
                national drug use measurement instruments and 
                techniques to measure the casual drug use population, 
                the addicted drug user population, and groups that are 
                at risk for drug use;
                    ``(C) the adequacy of the coverage of existing 
                national treatment outcome monitoring systems to 
                measure the effectiveness of drug abuse treatment in 
                reducing drug use and criminal behavior during and 
                after the completion of substance abuse treatment; and
                    ``(D) the actions the Director shall take to 
                correct any deficiencies and limitations identified 
                pursuant to subparagraphs (A) and (B) of this 
                subsection.
    ``(d) Modifications.--A description of any modifications made 
during the preceding year to the national drug performance measurement 
system described in subsection (c) shall be included in each report 
submitted under subsection (b).''.

 TITLE III--HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM AND COUNTER-
                   DRUG TECHNOLOGY ASSESSMENT CENTER

SEC. 301. PURPOSE OF HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM.

    Section 707(a) is amended--
            (1) by striking ``There is'' and inserting the following:
            ``(1) In general.--There is''; and
            (2) by adding at the end the following:
            ``(2) Purpose.--The purpose of the High Intensity Drug 
        Trafficking Areas program is to reduce drug trafficking and 
drug production in designated areas in the United States by--
                    ``(A) facilitating cooperation among Federal, 
                State, and local law enforcement agencies to share 
                information and implement coordinated enforcement 
                activities;
                    ``(B) enhancing intelligence sharing among Federal, 
                State, and local law enforcement agencies;
                    ``(C) providing reliable intelligence to law 
                enforcement agencies needed to design effective 
                enforcement strategies and operations; and
                    ``(D) supporting coordinated law enforcement 
                strategies which maximize use of available resources to 
                reduce the supply of illegal drugs in HIDTA designated 
                areas.''.

SEC. 302. DESIGNATION OF HIDTAS AND EVALUATION OF HIDTA PERFORMANCE.

    (a) Consultation.--Section 707(b) is amended by striking 
``Secretary of the Treasury,'' and inserting ``the Secretary of 
Homeland Security,''.
    (b) Factors for Consideration.--Section 707(c) is amended--
            (1) in paragraph (1), by inserting ``significant'' before 
        ``center''; and
            (2) by striking paragraph (3) and inserting the following:
            ``(3) drug-related production, manufacturing, importation, 
        or distribution in the area is having a significant harmful 
        local or regional impact; and''.
    (c) Evaluation of HIDTA Performance.--Section 707 is amended by 
adding at the end the following:
    ``(e) Evaluation.--
            ``(1) Initial report.--Not later than 90 days after 
        enactment of the Office of National Drug Control Policy 
        Reauthorization Act of 2003, the Director shall, after 
        consulting with the Executive Boards of each designated HIDTA, 
        submit a report to Congress which describes, for each 
        designated HIDTA--
                    ``(A) the specific purposes for the HIDTA;
                    ``(B) the specific long-term and short-term goals 
                and objectives for the HIDTA;
                    ``(C) the measurements which will be used to 
                evaluate the performance of the HIDTA in achieving the 
                long-term and short-term goals; and
                    ``(D) the reporting requirements needed to evaluate 
                the performance of the HIDTA in achieving the long-term 
                and short-term goals.
            ``(2) Evaluation of hidta program as part of national drug 
        control strategy.--For each designated HIDTA, the Director 
        shall submit, as part of the annual National Drug Control 
        Strategy, a report that--
                    ``(A) describes--
                            ``(i) the specific purposes for the HIDTA; 
                        and
                            ``(ii) the specific long-term and short-
                        term goals and objectives for the HIDTA; and
                    ``(B) includes an evaluation of the performance of 
                the each HIDTA in accomplishing the specific long-term 
                and short-term goals and objectives identified under 
                paragraph (1)(B).''.

SEC. 303. ORGANIZATION OF HIDTAS.

    Section 707 is amended by adding at the end the following:
    ``(f) Organization of HIDTAs.--
            ``(1) Executive board and officers.--Each HIDTA shall be 
        governed by an Executive Board. The Executive Board shall 
        designate a President, Vice President, and any other officers 
        to the Board that it determines is necessary.
            ``(2) Membership.--The membership of the Board shall 
        consist of--
                    ``(A) an equal number of representatives from--
                            ``(i) Federal law enforcement; and
                            ``(ii) State and local law enforcement; and
                    ``(B) any other representative the Board determines 
                would be appropriate.
            ``(3) Responsibilities.--The Executive Board shall be 
        responsible for--
                    ``(A) taking all necessary actions to ensure that 
                the mission of the HIDTA is achieved;
                    ``(B) managing the HIDTA;
                    ``(C) reviewing and approving all funding proposals 
                consistent with the overall objective of the HIDTA; and
                    ``(D) preparing and reviewing all reports to the 
                Director on the HIDTA's activities.''.

SEC. 304. HIDTA FUNDING.

    Section 707 is amended by adding at the end the following:
    ``(g) Funding.--
            ``(1) Appropriations.--There are authorized to be 
        appropriated for funding activities of high intensity drug 
        trafficking areas under this section--
                    ``(A) $280,000,000 for fiscal year 2004;
                    ``(B) $290,000,000 for fiscal years 2005 and 2006; 
                and
                    ``(C) $300,000,000 for fiscal years 2007 and 2008.
            ``(2) Annual hidta program budget submissions.--As part of 
        the documentation that supports the President's annual budget 
        request for the Office, the Director shall submit to Congress a 
        budget justification that includes the following:
                    ``(A) The amount requested for each HIDTA with 
                supporting narrative descriptions and rationale for 
                each request.
                    ``(B) A detailed justification for each funding 
                request which explains the reasons for the requested 
                funding level, how such funding level was determined 
                based on a current assessment of the drug trafficking 
                threat in each HIDTA, and how such funding will ensure 
                that the goals and objectives of each HIDTA will be 
                achieved.
            ``(3) Emerging threat response fund.--The Director may 
        request not more than 10 percent above the total requested 
funding for all HIDTAs for discretionary grants. Such funds may be used 
to respond to any emerging drug trafficking threat in an existing 
HIDTA, or to establish a new high intensity trafficking area in 
accordance with the provisions outlined in this Act.''.

SEC. 305. ASSESSMENT OF TASK FORCES IN HIDTA AREAS.

    Not later than 180 days after the date of enactment of this Act, 
the Director shall submit to Congress a report--
            (1) assessing the number and operation of all task forces 
        within each HIDTA; and
            (2) describing--
                    (A) each Federal, State, and/or local task force 
                operating in the HIDTA;
                    (B) how the task forces coordinate with each other, 
                with any HIDTA task force, and with Organized Crime and 
                Drug Enforcement Task Force investigations;
                    (C) what steps, if any, each task force takes to 
                share information with other task forces in the HIDTA 
                area;
                    (D) the role of the HIDTA in coordinating the 
                sharing of such information among task forces;
                    (E) the nature and extent of cooperation by each 
                Federal, State, and local participant in ensuring that 
                information is shared among law enforcement agencies 
                and with the HIDTA;
                    (F) the nature and extent to which such information 
                and enforcement activities are coordinated with Joint 
                Terrorism Task Forces in the HIDTA area; and
                    (G) any recommendations for measures needed to 
                ensure that task force resources are utilized 
                efficiently and effectively to reduce the availability 
                of illegal drugs in the HIDTA areas.

SEC. 306. FUNDING FOR CERTAIN HIGH INTENSITY DRUG TRAFFICKING AREAS.

    (a) Short Title.--This section may be cited as the ``Dawson Family 
Community Protection Act''.
    (b) Findings.--Congress finds the following:
            (1) In the early morning hours of October 16, 2002, the 
        home of Carnell and Angela Dawson was firebombed in apparent 
        retaliation for Mrs. Dawson's notification of police about 
        persistent drug distribution activity in their East Baltimore 
        City neighborhood.
            (2) The arson claimed the lives of Mr. and Mrs. Dawson and 
        their 5 young children, aged 9 to 14.
            (3) The horrific murder of the Dawson family is a stark 
        example of domestic narco-terrorism.
            (4) In all phases of counter-narcotics law enforcement--
        from prevention to investigation to prosecution to reentry--the 
        voluntary cooperation of ordinary citizens is a critical 
        component.
            (5) Voluntary cooperation is difficult for law enforcement 
        officials to obtain when citizens feel that cooperation carries 
        the risk of violent retaliation by illegal drug trafficking 
        organizations and their affiliates.
            (6) Public confidence that law enforcement is doing all it 
        can to make communities safe is a prerequisite for voluntary 
        cooperation among people who may be subject to intimidation or 
        reprisal (or both).
            (7) Witness protection programs are insufficient on their 
        own to provide security because many individuals and families 
        who strive every day to make distressed neighborhoods livable 
        for their children, other relatives, and neighbors will resist 
        or refuse offers of relocation by Federal, State, and local 
        prosecutorial agencies and because, moreover, the continued 
        presence of strong individuals and families is critical to 
        preserving and strengthening the social fabric in such 
        communities.
            (8) Where (as in certain sections of Baltimore City) 
        interstate trafficking of illegal drugs has severe ancillary 
        local consequences within areas designated as high intensity 
        drug trafficking areas, it is important that supplementary High 
        Intensity Drug Trafficking Areas Program funds be committed to 
        support initiatives aimed at making the affected communities 
        safe for the residents of those communities and encouraging 
        their cooperation with Federal, State, and local law 
        enforcement efforts to combat illegal drug trafficking.
    (c) Funding for Certain High Intensity Drug Trafficking Areas.--
Section 707(h) (21 U.S.C. 1706) is amended by adding at the end the 
following:
            ``(6) Specific purposes.--
                    ``(A) In general.--The Director shall ensure that, 
                of the amounts appropriated for a fiscal year for the 
                Program, at least $1,000,000 is used in high intensity 
                drug trafficking areas with severe neighborhood safety 
                and illegal drug distribution problems.
                    ``(B) Required uses.--The funds used under 
                subparagraph (A) shall be used--
                            ``(i) to ensure the safety of neighborhoods 
                        and the protection of communities, including 
                        the prevention of the intimidation of potential 
                        witnesses of illegal drug distribution and 
                        related activities; and
                            ``(ii) to combat illegal drug trafficking 
                        through such methods as the Director considers 
                        appropriate, such as establishing or operating 
                        (or both) a toll-free telephone hotline for use 
                        by the public to provide information about 
                        illegal drug-related activities.''.

SEC. 307. REPORT ON INTELLIGENCE SHARING.

    Not later than 180 days after the date of enactment of this Act, 
the Director shall submit to Congress a report--
            (1) evaluating existing and planned intelligence systems 
        used by Federal, State, and local law enforcement agencies 
        responsible for drug trafficking and drug production 
        enforcement; and
            (2) addressing--
                    (A) the current intelligence systems used by 
                Federal, State, and local law enforcement agencies;
                    (B) the compatibility of such systems in ensuring 
                access and availability of intelligence to Federal, 
                State, and local law enforcement;
                    (C) the extent to which Federal, State, and local 
                law enforcement are sharing intelligence information to 
                assess current threats and design appropriate 
                enforcement strategies; and
                    (D) the measures needed to ensure and to promote 
                effective information sharing among intelligence 
                systems operated by Federal, State, and local law 
                enforcement agencies responsible for drug trafficking 
                and drug production enforcement.

SEC. 308. COUNTER-DRUG TECHNOLOGY ASSESSMENT CENTER.

    (a) Chief Scientist.--Section 708(b) is amended to read as follows:
    ``(b) Chief Scientist.--There shall be at the head of the Center 
the Chief Scientist, who shall be appointed by the Director from among 
individuals qualified and distinguished in the area of science, 
medicine, engineering, or technology.''.
    (b) Responsibilities.--
            (1) Research and development.--Section 708 is amended by--
                    (A) redesignating subsection (d) as subsection (e); 
                and
                    (B) striking subsection (c) and inserting the 
                following:
    ``(c) Research and Development Responsibilities.--The Chief 
Scientist shall be responsible to the Director for--
            ``(1) identifying and defining the short-, medium-, and 
        long-term scientific and technological needs of Federal, State, 
        and local drug supply reduction agencies, including--
                    ``(A) advanced surveillance, tracking, and radar 
                imaging;
                    ``(B) electronic support measures;
                    ``(C) communications;
                    ``(D) data fusion, advanced computer systems, and 
                artificial intelligence; and
                    ``(E) chemical, biological, radiological (including 
                neutron and electron), and other means of detection;
            ``(2) identifying demand reduction basic and applied 
        research needs and initiatives, in consultation with affected 
        National Drug Control Program agencies, including--
                    ``(A) improving treatment through neuroscientific 
                advances;
                    ``(B) improving the transfer of biomedical research 
                to the clinical setting; and
                    ``(C) in consultation with the National Institute 
                of Drug Abuse, and through interagency agreements or 
                grants, examining addiction and rehabilitation research 
                and the application of technology to expanding the 
                effectiveness of availability of drug treatment;
            ``(3) making a priority ranking of such needs identified in 
        paragraphs (1) and (2) according to fiscal and technological 
        feasibility, as part of a National Counter-Drug Research and 
        Development Program;
            ``(4) overseeing and coordinating counter-drug technology 
        initiatives with related activities of other Federal civilian 
        and military departments;
            ``(5) providing support to the development and 
        implementation of the national drug control performance 
        measurement system established under subsection (c) of section 
        706; and
            ``(6) transferring funds made available to a National Drug 
        Control Program agency for counter-drug technology research and 
        development to another account within such agency or to another 
        National Drug Control Program agency for counter-drug 
        technology research and development, pursuant to the authority 
        of the Director under section 704.
    ``(d) Limitation on Authority.--The authority granted to the 
Director under this section shall not extend to the awarding of 
contracts, management of individual projects, or other operational 
activities.''.
            (2) Assistance and support.--Subsection (e) of section 708, 
        as redesignated by this section, is amended to read as follows:
    ``(e) Assistance and Support to the Office of National Drug Control 
Policy.--The Secretary of Defense, the Secretary of Homeland Security, 
and the Secretary of Health and Human Services shall, to the maximum 
extent practicable, render assistance and support to the Office and to 
the Director in the conduct of Counterdrug technology assessment.''.
            (3) Technology transfer program.--Section 708 is amended by 
        adding at the end the following:
    ``(f) Technology Transfer Program.--
            ``(1) Program.--The Chief Scientist, with the advice and 
        counsel of experts from State and local law enforcement 
        agencies, shall be responsible to the Director for coordination 
        and implementation of a counter-drug technology transfer 
        program.
            ``(2) Purpose.--The purpose of the Technology Transfer 
        Program shall be for the Counterdrug Technology Assessment 
        Center to transfer technology and associated training directly 
        to State and local law enforcement agencies.
            ``(3) Priority of receipts.--Transfers shall be made in 
        priority order based on--
                    ``(A) the need of potential recipients for such 
                technology;
                    ``(B) the effectiveness of the technology to 
                enhance current counter-drug activities of potential 
                recipients; and
                    ``(C) the ability and willingness of potential 
                recipients to evaluate transferred technology.
            ``(4) Agreement authority.--The Director may enter into an 
        agreement with the Secretary of Homeland Security to transfer 
        technology with both counter-drug and homeland security 
        applications to State and local law enforcement agencies on a 
        reimbursable basis.
            ``(5) Report.--On or before July 1 of each year, the 
        Director shall submit a report to the appropriate congressional 
        committees which addresses the following:
                    ``(A) The number of requests received during the 
                previous 12 months.
                    ``(B) The number of requests fulfilled during the 
                previous 12 months.
                    ``(C) A summary of the criteria used in making the 
                determination on what requests were funded and what 
                requests were not funded.
                    ``(D) A general assessment of the future needs of 
                the program, based on expected changes in threats, 
                expected technologies, and likely need from potential 
                recipients.
                    ``(E) An assessment of the effectiveness of the 
                technologies transferred, based in part on the 
                evaluations provided by the recipients, with a 
                recommendation whether the technology should continue 
                to be offered through the program.''.

  TITLE IV--REAUTHORIZATION AND IMPROVEMENT OF THE NATIONAL ANTI-DRUG 
                             MEDIA CAMPAIGN

SEC. 401. SHORT TITLE.

    This title may be cited as the ``National Youth Anti-Drug Media 
Campaign Reauthorization Act of 2003''.

SEC. 402. PURPOSES OF THE NATIONAL ANTI-DRUG MEDIA CAMPAIGN.

    The Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 et seq.) 
is amended--
            (1) in section 101, by striking ``Drug-Free Media Campaign 
        Act of 1998'' and inserting ``National Youth Anti-Drug Media 
        Campaign Act''; and
            (2) in section 102--
                    (A) in subsection (a), by striking ``national media 
                campaign'' and all that follows through the period and 
                inserting the following: ``national youth anti-drug 
                media campaign (referred to in this subtitle as the 
                `national media campaign') in accordance with this 
                subtitle for the purposes of--
            ``(1) preventing drug abuse among young people in the 
        United States;
            ``(2) increasing awareness of adults of the impact of drug 
        abuse on young people; and
            ``(3) encouraging parents and other interested adults to 
        discuss with young people the dangers of illegal drug use.''; 
        and
                    (B) in subsection (b), by striking ``105'' and 
                inserting ``106''.

SEC. 403. ROLES AND RESPONSIBILITIES OF THE DIRECTOR, THE PARTNERSHIP 
              FOR A DRUG-FREE AMERICA, AND A MEDIA BUYING CONTRACTOR.

    The Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 et seq.) 
is amended--
            (1) by adding at the end the following:
    ``(c) Division of Responsibilities and Functions Under the 
Program.--
            ``(1) In general.--The Director, in consultation with the 
        Partnership for a Drug-Free America, shall determine the 
        overall purposes and strategy of the national media campaign.
            ``(2) Responsibilities.--
                    ``(A) Director.--The Director shall be responsible 
                for implementing a focused national media campaign to 
                meet the purposes set forth in section 102(a), and 
                shall approve--
                            ``(i) the strategy of the national media 
                        campaign;
                            ``(ii) all advertising and promotional 
                        material used in the national media campaign; 
                        and
                            ``(iii) the plan for the purchase of 
                        advertising time and space for the national 
                        media campaign.
                    ``(B) The partnership for a drug-free america.--The 
                Director shall request that the Partnership for a Drug-
                Free America--
                            ``(i) develop and recommend strategies to 
                        achieve the goals of the national media 
                        campaign that address national and local drug 
                        threats in specific regions or States, such as 
                        methamphetamine and ecstasy;
                            ``(ii) create all advertising to be used in 
                        the national media campaign, except 
                        advertisements that are--
                                    ``(I) provided by other nonprofit 
                                entities pursuant to section 103(c);
                                    ``(II) intended to reach a 
                                minority, ethnic, or other special 
                                audience that cannot be obtained at no 
                                cost (not including production costs 
                                and talent reuse payments), provided 
                                that any such advertising material is 
                                reviewed and approved by the 
                                Partnership for a Drug-Free America; 
                                and
                                    ``(III) any other advertisements 
                                that the Partnership for a Drug-Free 
                                America determines it is unable to 
                                provide;
                    ``(C) Media buying contractor.--The Director shall 
                enter into a contract with a media buying contractor to 
                plan and purchase advertising time and space for the 
                national media campaign. The media buying contractor 
                shall not provide any service or material, or conduct 
                any function or activity which can be provided by the 
                Partnership for a Drug Free America''; and
            (2) in section 103--
                    (A) in subparagraph (A), by inserting ``, including 
                the strategic planning for, and accounting of, such 
                purchases'' after ``space'';
                    (B) in subparagraph (C), by striking ``out-of-
                pocket''; and
                    (C) in subparagraph (F), by striking ``the Office 
                of National Drug Control Policy'' and inserting 
                ``either the Office of National Drug Control Policy or 
                the designee of the Office''.

SEC. 404. RESPONSIBLE USE OF FEDERAL FUNDS FOR THE NATIONAL ANTI-DRUG 
              MEDIA CAMPAIGN.

    The Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 et seq.) 
is amended--
            (1) in section 103, by striking paragraph (2) and inserting 
        the following:
            ``(2) Advertising.--
                    ``(A) In general.--Except as provided in 
                subparagraph (B), in carrying out this subtitle, the 
                Director shall ensure that sufficient funds are 
                allocated to meet the stated goals of the national 
                media campaign.
                    ``(B) Exception.--No funds shall be used for the 
                creative development of advertisements (not including 
                out-of-pocket production costs and talent reuse 
                payments) except when--
                            ``(i) the advertisements are intended to 
                        reach a minority, ethnic, or other special 
                        audience that cannot be obtained at no cost 
                        (not including production costs and talent 
                        reuse payments);
                            ``(ii) the Partnership for a Drug-Free 
                        America is unable to provide such 
                        advertisements; and
                            ``(iii) the Director receives prior 
                        approval from the appropriate congressional 
                        committees.'';
            (2) in subsection (b), by striking ``105'' and inserting 
        ``106'';
            (3) by striking subsection (c) and inserting the following:
    ``(c) Matching Requirement.--
            ``(1) No cost match.--
                    ``(A) In general.--Except as provided in 
                subparagraph (B), amounts made available for the 
                national media campaign under section 106 shall be used 
                to require a no cost match of equivalent value of 
                advertising broadcast time, print space, or in-kind 
                contributions to the national media campaign, prior to 
                the Director executing a contract for the purchase of 
                any advertising time or space for the national media 
                campaign.
                    ``(B) Exception.--The Director shall ensure that 
                all no cost matches of advertising material, time, 
                space, or in-kind contributions provided pursuant to 
                subparagraph (A) directly relate to substance abuse 
                prevention and specifically promote the specific 
                purposes set forth in section 102(a).
            ``(2) Sponsorship identification.--Any advertising material 
        donated to the national media campaign at no cost shall not be 
        subject to the sponsorship identification provisions in section 
        317 of the Communications Act of 1934 (47 U.S.C. 317).'';
            (4) by adding at the end the following:
    ``(d) Responsible Use of Federal Funds.--
            ``(1) In general.--The Director shall ensure that--
                    ``(A) for each fiscal year, not less than 85 
                percent of the amounts appropriated under this subtitle 
                shall be used for the purchase of advertising time and 
                space for the national media campaign;
                    ``(B) no Federal funds are used to pay any entity 
                for any activity or service that duplicates, in whole 
                or in part, any material, function, activity, or 
                service provided by the Partnership for a Drug-Free 
                America;
                    ``(C) no more than $5,000,000 is used in each 
                fiscal year to develop advertising material pursuant to 
                subsection (a)(2)(B)(ii); and
                    ``(D) a corporation, partnership, or individual, 
                shall not be considered a bidder for a contract under 
                this subtitle if such corporation, partnership, or 
                individual has, within the previous 10-year period, in 
                connection with the national media campaign--
                            ``(i) been convicted of any Federal 
                        criminal offense;
                            ``(ii) been subject to any Federal civil 
                        judgment or penalty in a civil proceeding 
                        instituted by the United States; or
                            ``(iii) settled any Federal civil 
                        proceeding or potential proceeding instituted 
                        by the United States.
            ``(2) New contract.--Notwithstanding any other provision of 
        law, if a corporation, partnership, or individual does not 
        qualify for consideration under paragraph (1)(B), then not 
        later than 90 days after the date of enactment of the National 
        Youth Anti-Drug Media Campaign Reauthorization Act of 2003, the 
        Director shall--
                    ``(A) terminate any existing contract prior to the 
                expiration; or
                    ``(B) prior to exercising any option to extend or 
                to renew any contract that is in effect on the date of 
                introduction of the National Youth Anti-Drug Media 
                Campaign Reauthorization Act of 2003, publish a notice 
                of solicitation of bids for a new contract for the 
                purchase of advertising time and space, provided that 
                termination of the existing contract and any 
                solicitation of a new contract shall be carried out in 
                a manner to ensure that the national media campaign is 
                not interrupted until the execution of the new 
                contract.
            ``(3) Congressional notification.--Prior to entering into a 
        contract for the purchase of advertising time and space in 
        accordance with this subsection, the Director shall notify 
        appropriate congressional committees.'';
            (5) by striking section 104 and inserting the following:

``SEC. 104. FINANCIAL AND PERFORMANCE ACCOUNTABILITY.

    ``The Director shall--
            ``(1) carry out (through the Defense Contract Audit Agency 
        or an independent auditor) an examination of records as 
        described in section 304C of the Federal Property and 
        Administrative Services Act of 1949 (41 U.S.C. 254d) and an 
        audit of the costs described in section 306 of that Act (41 
        U.S.C. 256);
            ``(2) annually evaluate the effectiveness of the national 
        media campaign based on--
                    ``(A) the `Monitoring the Future Study' published 
                by the Department of Health and Human Services;
                    ``(B) the Attitude Tracking Study published by the 
                Partnership for a Drug-Free America; and
                    ``(C) other relevant studies or publications, as 
                determined by the Director, including tracking and 
                evaluation data collected according to marketing and 
                advertising industry standards; and
            ``(3) submit a report to Congress in accordance with 
        section 105, including the evaluation referred to in paragraph 
        (2).''; and
            (6) by striking section 105 and inserting the following:

``SEC. 105. REPORT TO CONGRESS.

    ``The Director shall annually submit a report to Congress that 
describes--
            ``(1) the strategy of the national media campaign and 
        whether specific objectives of the campaign were accomplished;
            ``(2) steps taken to ensure that the national media 
        campaign operates in an effective and efficient manner 
        consistent with the overall strategy and focus of the campaign;
            ``(3) plans to purchase advertising time and space;
            ``(4) policies and practices implemented to ensure that 
        Federal funds are used responsibly to purchase advertising time 
        and space and eliminate the potential for waste, fraud, and 
        abuse;
            ``(5) all contracts entered into with a corporation, 
        partnership, or individual working on behalf of the national 
        media campaign;
            ``(6) specific policies and steps implemented to ensure 
        compliance with this subtitle;
            ``(7) steps taken to ensure that the national media 
        campaign will secure, to the maximum extent possible, no cost 
        matches of advertising time and space or in-kind contributions 
        that are directly related to the campaign in accordance with 
        this subtitle; and
            ``(8) a review and evaluation of the effectiveness of the 
        national media campaign strategy for the past year.''.

SEC. 405. GAO AUDIT OF NATIONAL MEDIA CAMPAIGN.

    (a) In General.--Not later than 1 year after the date of enactment 
of this Act, the General Accounting Office shall report to Congress on 
the national media campaign.
    (b) Contents.--The report described in subsection (a) shall include 
information an assessment of--
            (1) the strategy, objectives and policies and practices of 
        the campaign;
            (2) the Office's management and strategic focus on the 
        campaign;
            (3) the steps taken to ensure that the campaign operates 
        effectively and minimizes the potential for waste, fraud, and 
        abuse.
            (4) the roles of the Office, the Partnership for a Drug 
        Free America, and the Media Buying Contractor, and the 
        coordination of their efforts;
            (5) the existence, if any, of any duplication of roles and 
        responsibilities between the Partnership for a Drug Free 
        America and the Media Buying Contractor;
            (6) the policies and practices for supervising contractors 
        who assist in the national media campaign;
            (7) the manner in which advertising time and space and no-
        cost matches are obtained;
            (8) the coordination of the national media campaign among 
        different media outlets; and
            (9) potential reforms to the management and operation of 
        the national media campaign to ensure that the campaign 
        operates effectively and efficiently.

SEC. 406. AUTHORIZATION FOR NATIONAL MEDIA CAMPAIGN.

    The Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 et seq) is 
amended by adding at the end the following:

``SEC. 106. AUTHORIZATION OF APPROPRIATIONS.

    ``There is authorized to be appropriated to the Office of National 
Drug Control Policy to carry out this subtitle, $195,000,000 for each 
of the fiscal years 2004 through 2008.''.

       TITLE V--AUTHORIZATIONS AND EXTENSION OF TERMINATION DATE

SEC. 501. AUTHORIZATION OF APPROPRIATIONS.

    Section 714 is amended--
            (1) by striking ``title,'' and inserting ``title except 
        activities otherwise specified,''; and
            (2) by striking ``1999 through 2003'' and inserting ``2004 
        through 2008''.

SEC. 502. EXTENSION OF TERMINATION DATE.

    Section 715(a) is amended by striking ``September 30, 2003, this 
title and the amendments made by this title'' and inserting ``September 
30, 2008, this title and the amendments made to this title''.

       TITLE VI--DESIGNATION OF UNITED STATES ANTI-DOPING AGENCY

SEC. 601. DESIGNATION OF UNITED STATES ANTI-DOPING AGENCY.

    (a) Definitions.--In this title:
            (1) United states olympic committee.--The term ``United 
        States Olympic Committee'' means the organization established 
        by the ``Ted Stevens Olympic and Amateur Sports Act'' (36 
        U.S.C. 220501 et seq.).
            (2) Amateur athletic competition.--The term ``amateur 
        athletic competition'' means a contest, game, meet, match, 
        tournament, regatta, or other event in which amateur athletes 
        compete (36 U.S.C. 220501(b)(2)).
            (3) Amateur athlete.--The term ``amateur athlete'' means an 
        athlete who meets the eligibility standards established by the 
        national governing body or paralympic sports organization for 
        the sport in which the athlete competes (36 U.S.C. 
        22501(b)(1)).
    (b) In General.--The United States Anti-Doping Agency shall--
            (1) serve as the independent anti-doping organization for 
        the amateur athletic competitions recognized by the United 
        States Olympic Committee;
            (2) ensure that athletes participating in amateur athletic 
        activities recognized by the United States Olympic Committee 
        are prevented from using performance-enhancing drugs;
            (3) implement anti-doping education, research, testing, and 
        adjudication programs to prevent United States Amateur Athletes 
        participating in any activity recognized by the United States 
        Olympic Committee from using performance-enhancing drugs; and
            (4) serve as the United States representative responsible 
        for coordination with other anti-doping organizations 
        coordinating amateur athletic competitions recognized by the 
        United States Olympic Committee to ensure the integrity of 
        athletic competition, the health of the athletes and the 
        prevention of use of performance-enhancing drugs by United 
        States amateur athletes.

SEC. 602. AUTHORIZATION OF APPROPRIATIONS.

    There are authorized to be appropriated to the United States Anti-
Doping Agency--
            (1) for fiscal year 2004, $7,200,000;
            (2) for fiscal year 2005, $9,200,000;
            (3) for fiscal year 2006, $9,500,000;
            (4) for fiscal year 2007, $9,900,000; and
            (5) for fiscal year 2008, $10,500,000.

          TITLE VII--DRUG EDUCATION, PREVENTION, AND TREATMENT

SEC. 701. EXPANSION OF SUBSTANCE ABUSE EDUCATION AND PREVENTION 
              EFFORTS.

    (a) Expansion of Efforts.--Section 515 of the Public Health Service 
Act (42 U.S.C. 290bb-21) is amended by adding at the end the following:
    ``(e)(1) The Director of the Prevention Center may make grants to 
and enter into contracts and cooperative agreements with public and 
nonprofit private entities to enable such entities--
            ``(A) to carry out school-based programs concerning the 
        dangers of abuse of and addiction to illicit drugs, using 
        methods that are effective and research-based, including 
        initiatives that give students the responsibility to create 
        their own antidrug abuse education programs for their schools; 
        and
            ``(B) to carry out community-based abuse and addiction 
        prevention programs relating to illicit drugs that are 
        effective and research-based.
    ``(2) Amounts made available under a grant, contract, or 
cooperative agreement under paragraph (1) shall be used for planning, 
establishing, or administering prevention programs relating to illicit 
drugs in accordance with paragraph (3).
    ``(3)(A) Amounts provided under this subsection may be used--
            ``(i) to carry out school-based programs that are focused 
        on those districts with high or increasing rates of drug abuse 
        and addiction and targeted at populations which are most at-
        risk to start abuse of illicit drugs;
            ``(ii) to carry out community-based prevention programs 
        that are focused on those populations within the community that 
        are most at-risk for abuse of and addiction to illicit drugs;
            ``(iii) to assist local government entities to conduct 
        appropriate prevention activities relating to illicit drugs;
            ``(iv) to train and educate State and local law enforcement 
        officials, prevention and education officials, members of 
        community antidrug coalitions and parents on the signs of abuse 
        of and addiction to illicit drugs, and the options for 
        treatment and prevention;
            ``(v) for planning, administration, and educational 
        activities related to the prevention of abuse of and addiction 
        to illicit drugs;
            ``(vi) for the monitoring and evaluation of prevention 
        activities relating to illicit drugs, and reporting and 
        disseminating resulting information to the public; and
            ``(vii) for targeted pilot programs with evaluation 
        components to encourage innovation and experimentation with new 
        methodologies.
    ``(B) The Director of the Prevention Center shall give priority in 
making grants under this subsection to rural States, urban areas, and 
other areas that are experiencing a high rate or rapid increases in 
drug abuse and addiction.
    ``(4)(A) Not less than $500,000 of the amount available in each 
fiscal year to carry out this subsection shall be made available to the 
Administrator, acting in consultation with other Federal agencies, to 
support and conduct periodic analyses and evaluations of effective 
prevention programs for abuse of and addiction to illicit drugs and the 
development of appropriate strategies for disseminating information 
about and implementing these programs.
    ``(B) The Administrator shall submit to the committees of Congress 
referred to in subparagraph (C) an annual report with the results of 
the analyses and evaluation conducted pursuant to subparagraph (A).
    ``(C) The committees of Congress referred to in subparagraph (B) 
are the following:
            ``(i) The Committees on Health, Education, Labor, and 
        Pensions, the Judiciary, and Appropriations of the Senate.
            ``(ii) The Committees on Energy and Commerce, the 
        Judiciary, and Appropriations of the House of 
        Representatives.''.
    (b) Authorization of Appropriations for Expansion of Abuse 
Prevention Efforts and Practitioner Registration Requirements.--There 
is authorized to be appropriated to carry out section 515(e) of the 
Public Health Service Act (as added by subsection (a)) and section 
303(g)(2) of the Controlled Substances Act (as added by section 18(a) 
of this Act), $100,000,000 for fiscal year 2005, and such sums as may 
be necessary for each succeeding fiscal year.
    (c) Minimum Allocation.--Unless all eligible applications submitted 
by any State or unit of local government within such State for a grant 
under this section have been funded, such State, together with grantees 
within the State (other than Indian tribes), shall be allocated in each 
fiscal year under this section not less than 0.75 percent of the total 
amount appropriated in the fiscal year for grants pursuant to this 
section.

SEC. 702. FUNDING FOR RURAL STATES AND ECONOMICALLY DEPRESSED 
              COMMUNITIES.

    Subpart 1 of part B of title 5 of the Public Health Service Act (42 
U.S.C. 290bb et seq.) is amended by inserting after section 509 the 
following:

``SEC. 510. FUNDING FOR RURAL STATES AND ECONOMICALLY DEPRESSED 
              COMMUNITIES.

    ``(a) In General.--The Director of the Center for Substance Abuse 
Treatment (in this section referred to as the `Director') may award 
grants, cooperative agreements, or contracts to public and nonprofit 
private entities for the purpose of providing treatment facilities in 
rural States and economically depressed communities that have high 
rates of drug addiction but lack the resources to provide adequate 
treatment.
    ``(b) Duration of Award.--The Director shall award grants, 
cooperative agreements, and contracts under subsection (a) for a period 
not to exceed 5 years. Such awards shall be subject to annual approval 
by the Director and subject to the availability of appropriations for 
the fiscal year involved. This subsection may not be construed to 
establish a limitation on the number of awards that may be made to an 
entity.
    ``(c) Equitable Allocation of Awards.--In making awards under 
subsection (a), the Director shall ensure that the awards are equitably 
allocated among the principal geographic regions of the United States, 
subject to the availability of qualified applicants for the awards.
    ``(d) Application.--Each entity desiring an award under subsection 
(a) shall submit to the Director an application at such time, in such 
manner and containing such information as the Director determines 
necessary, including a certification that--
            ``(1) the entity has the capacity to carry out a program 
        described in subsection (a);
            ``(2) the plans of the entity for such a program are 
        consistent with the policies of such entity regarding the 
        treatment of substance abuse; and
            ``(3) the entity, or any other entity through which the 
        applicant will provide services, meets all applicable State 
        licensure or certification requirements regarding the provision 
        of the services involved.
    ``(e) Requirement of Matching Funds.--
            ``(1) Non-federal share.--Each entity receiving an award 
        under this section shall make available (directly or through 
        donations from public or private entities) non-Federal 
        contributions toward the costs of activities funded by such an 
        award in an amount that--
                    ``(A) for the first fiscal year for which the 
                applicant receives payments under the award, shall be 
                not less than $1 for each $9 of Federal funds provided 
                in the award;
                    ``(B) for any second such fiscal year, shall be not 
                less than $1 for each $9 of Federal funds provided in 
                the award; and
                    ``(C) for any subsequent fiscal year, shall be not 
                less than $1 for each $3 of Federal funds provided in 
                the award.
            ``(2) Determination of amount of non-federal share.--The 
        non-Federal share of payments required under paragraph (1) may 
        be in cash or in kind, fairly evaluated, including plant, 
        equipment, or services. Amounts provided by the Federal 
        Government, or services assisted or subsidized to any 
        significant extent by the Federal Government, may not be 
        included in determining the amount of such non-Federal 
        contributions.
    ``(f) Reports to Director.--Not later than 1 year after receiving 
an award under subsection (a) and annually thereafter, each entity 
receiving an award under such subsection shall submit to the Director a 
report--
            ``(1) describing the use of the award and the costs of 
        services provided under the award;
            ``(2) specifying the number of individuals served by the 
        award and the type and cost of services provided; and
            ``(3) providing such other information as the Director 
        determines to be appropriate.
    ``(g) Evaluations; Dissemination of Findings.--The Director shall, 
directly or through contract, provide for the conduct of evaluations of 
programs carried out pursuant to subsection (a). The Director shall 
disseminate to the States the findings made as a result of the 
evaluations.
    ``(h) Minimum Allocation.--Unless all eligible applications 
submitted by any State or unit of local government within such State 
for a grant under this section have been funded, such State, together 
with grantees within the State (other than Indian tribes), shall be 
allocated in each fiscal year under this section not less than 0.75 
percent of the total amount appropriated in the fiscal year for grants 
under this section.
    ``(i) Definition of Rural State.--In this section, the term `rural 
State' has the meaning given such term in section 1501(b) of the 
Omnibus Crime Control and Safe Streets Act of 1968 (42 U.S.C. 
3796bb(B)).
    ``(j) Authorization of Appropriations.--There are authorized to be 
appropriated to carry out this section $50,000,000 for each of fiscal 
years 2005, 2006, and 2007.

``SEC. 511. FUNDING FOR RESIDENTIAL TREATMENT CENTERS FOR WOMEN AND 
              CHILDREN.

    ``(a) In General.--The Director of the Center for Substance Abuse 
Treatment (in this section referred to as the `Director') may award 
grants, cooperative agreements, or contracts to public and nonprofit 
private entities to establish treatment facilities that--
            ``(1) provide residential treatment for methamphetamine-, 
        heroin-, and other drug-addicted women with minor children; and
            ``(2) offer specialized treatment for methamphetamine-, 
        heroin-, and other drug-addicted mothers and allow the minor 
        children of those mothers to reside with them in the facility 
        or nearby while treatment is ongoing.
    ``(b) Duration of Award.--The Director shall award grants, 
cooperative agreements, and contracts under subsection (a) for a period 
not to exceed 5 years. Such awards shall be subject to annual approval 
by the Director and subject to the availability of appropriations for 
the fiscal year involved. This subsection may not be construed to 
establish a limitation on the number of awards that may be made to an 
entity.
    ``(c) Equitable Allocation of Awards.--In making awards under 
subsection (a), the Director shall ensure that the awards are equitably 
allocated among the principal geographic regions of the United States, 
subject to the availability of qualified applicants for the awards.
    ``(d) Application.--Each entity desiring an award under subsection 
(a) shall submit to the Director an application at such time, in such 
manner and containing such information as the Director determines 
necessary, including a certification that--
            ``(1) the entity has the capacity to carry out a program 
        described in subsection (a);
            ``(2) the plans of the entity for such a program are 
        consistent with the policies of such entity regarding the 
        treatment of substance abuse; and
            ``(3) the entity, or any other entity through which the 
        applicant will provide services, meets all applicable State 
        licensure or certification requirements regarding the provision 
        of the services involved.
    ``(e) Priority.--In making grants under this section, the Director 
shall give priority to areas experiencing a high rate or rapid increase 
in drug abuse and addiction.
    ``(f) Requirement of Matching Funds.--
            ``(1) Non-federal share.--Each entity receiving an award 
        under this section shall make available (directly or through 
        donations from public or private entities) non-Federal 
        contributions toward the costs of activities funded by such an 
        award in an amount that--
                    ``(A) for the first fiscal year for which the 
                applicant receives payments under the award, shall be 
                not less than $1 for each $9 of Federal funds provided 
                in the award;
                    ``(B) for any second such fiscal year, shall be not 
                less than $1 for each $9 of Federal funds provided in 
                the award; and
                    ``(C) for any subsequent fiscal year, shall be not 
                less than $1 for each $3 of Federal funds provided in 
                the award.
            ``(2) Determination of amount of non-federal share.--The 
        non-Federal share of payments required under paragraph (1) may 
        be in cash or in kind, fairly evaluated, including plant, 
        equipment, or services. Amounts provided by the Federal 
        Government, or services assisted or subsidized to any 
        significant extent by the Federal Government, may not be 
        included in determining the amount of such non-Federal 
        contributions.
    ``(g) Reports to Director.--Not later than 1 year after receiving 
an award under subsection (a) and annually thereafter, each entity 
receiving an award under such subsection shall submit to the Director a 
report--
            ``(1) describing the use of the award and the costs of 
        services provided under the award;
            ``(2) specifying the number of individuals served by the 
        award and the type and cost of services provided; and
            ``(3) providing such other information as the Director 
        determines to be appropriate.
    ``(h) Evaluations; Dissemination of Findings.--The Director shall, 
directly or through contract, provide for the conduct of evaluations of 
programs carried out pursuant to subsection (a). The Director shall 
disseminate to the States the findings made as a result of the 
evaluations.
    ``(i) Minimum Allocation.--Unless all eligible applications 
submitted by any State or units of local government within such State 
for a grant under this section have been funded, such State, together 
with grantees within the State (other than Indian tribes), shall be 
allocated in each fiscal year under this section not less than 0.75 
percent of the total amount appropriated in the fiscal year for grants 
under this section.
    ``(j) Authorization of Appropriations.--There are authorized to be 
appropriated to carry out this section $10,000,000 for each of fiscal 
years 2005, 2006, and 2007.''.

SEC. 703. RESIDENTIAL TREATMENT PROGRAMS FOR JUVENILES.

    Title V of the Public Health Service Act (42 U.S.C. 290aa et seq.) 
is amended by adding at the end the following:

         ``PART H--RESIDENTIAL TREATMENT PROGRAMS FOR JUVENILES

``SEC. 591. RESIDENTIAL TREATMENT PROGRAMS FOR JUVENILES.

    ``(a) In General.--The Director of the Center for Substance Abuse 
Treatment (in this section referred to as the `Director') may award 
grants, cooperative agreements, or contracts to public and nonprofit 
private entities to provide treatment to juveniles for substance abuse 
through programs that--
            ``(1) are effective and science-based; and
            ``(2) provide facilities in which the juveniles reside 
        during the course of receiving such treatment.
    ``(b) Duration of Award.--The Director shall award grants, 
cooperative agreements, and contracts under subsection (a) for a period 
not to exceed 5 years. Such awards shall be subject to annual approval 
by the Director and subject to the availability of appropriations for 
the fiscal year involved. This subsection may not be construed to 
establish a limitation on the number of awards that may be made to an 
entity.
    ``(c) Equitable Allocation of Awards.--In making awards under 
subsection (a), the Director shall ensure that the awards are equitably 
allocated among the principal geographic regions of the United States, 
as well as among Indian tribes, subject to the availability of 
qualified applicants for the awards.
    ``(d) Availability of Services for Each Participant.-- Each entity 
receiving an award under subsection (a) shall use the funds provided 
under such subsection to operate programs in which--
            ``(1) treatment services will be available either directly 
        or through agreements with other public or nonprofit private 
        entities;
            ``(2) services will be made available to each person 
        admitted to the program; and
            ``(3) the entity will, in consultation with the juvenile 
        and, if appropriate the parent or guardian of the juvenile, 
        prepare an individualized plan for the provision of treatment 
        services including--
                    ``(A) individual, group, and family counseling, as 
                appropriate, regarding substance abuse; and
                    ``(B) followup services to assist the juvenile or 
                young adult in preventing a relapse into such abuse.
    ``(e) Eligible Supplemental Services.--In addition to activities 
described in subsection (b), grants under subsection (a) may be used to 
provide the following services:
            ``(1) Referrals for necessary hospital services.
            ``(2) Counseling on the human immunodeficiency virus and on 
        acquired immune deficiency syndrome.
            ``(3) Counseling on domestic violence and sexual abuse.
            ``(4) Planning for and counseling to assist reentry into 
        society, both before and after discharge, including referrals 
        to any public or nonprofit private entities in the community 
        involved that provide services appropriate for the juvenile.
    ``(f) Application.--Each entity desiring an award under subsection 
(a) shall submit to the Director an application at such time, in such 
manner, and containing such information as the Director may require 
including a certification that--
            ``(1) the applicant has the capacity to carry out a program 
        described in subsection (a);
            ``(2) the plans of the applicant for the program are 
        consistent with the policies of such agency regarding the 
        treatment of substance abuse;
            ``(3) the applicant, or any entity through which the 
        applicant will provide services, meets all applicable State 
        licensure or certification requirements regarding the provision 
        of the services involved;
            ``(4) the applicant will provide outreach services in the 
        community involved to identify juveniles who are engaging in 
        substance abuse and to encourage the juveniles to undergo 
        treatment for such abuse;
            ``(5) the program will be operated at a location that is 
        accessible to low-income juveniles;
            ``(6) the applicant involved will provide for continuing 
        education in treatment services for the individuals who will 
        provide treatment in the program; and
            ``(7) if a charge is imposed for the provision of services 
        to or on behalf of a juvenile, such charge--
                    ``(A) will be made according to a schedule of 
                charges that is made available to the public;
                    ``(B) will be adjusted to reflect the economic 
                condition of the juvenile involved; and
                    ``(C) will not be imposed on any juvenile whose 
                family has an income of less than 185 percent of the 
                poverty line, as established by the Director of the 
                Office for Management and Budget and revised by the 
                Secretary in accordance with section 673(2) of the 
                Omnibus Budget Reconciliation Act of 1981 (42 U.S.C. 
                9902(2)).
    ``(g) Priority.--In making grants under this section, the Director 
shall give priority to areas experiencing a high rate or rapid increase 
in drug abuse and addiction.
    ``(h) Requirement of Matching Funds.--
            ``(1) Non-federal share.--Each entity receiving an award 
        under this section shall make available (directly or through 
        donations from public or private entities) non-Federal 
        contributions toward the costs of activities funded by such an 
        award in an amount that--
                    ``(A) for the first fiscal year for which the 
                applicant receives payments under the award, shall be 
                not less than $1 for each $9 of Federal funds provided 
                in the award;
                    ``(B) for any second such fiscal year, shall be not 
                less than $1 for each $9 of Federal funds provided in 
                the award; and
                    ``(C) for any subsequent fiscal year, shall be not 
                less than $1 for each $3 of Federal funds provided in 
                the award.
            ``(2) Determination of amount of non-federal share.--The 
        non-Federal share of payments required under paragraph (1) may 
        be in cash or in kind, fairly evaluated, including plant, 
        equipment, or services. Amounts provided by the Federal 
        Government, or services assisted or subsidized to any 
        significant extent by the Federal Government, may not be 
        included in determining the amount of such non-Federal 
        contributions.
    ``(i) Reports to Director.--Not later than 1 year after receiving 
an award under subsection (a) and annually thereafter, each entity 
receiving an award under such subsection shall submit to the Director a 
report--
            ``(1) describing the use of the award and the costs of 
        services provided under the award;
            ``(2) specifying the number of juveniles served by the 
        award and the type and cost of services provided; and
            ``(3) providing such other information as the Director 
        determines to be appropriate.
    ``(j) Evaluations; Dissemination of Findings.--The Director shall, 
directly or through contract, provide for the conduct of evaluations of 
programs carried out pursuant to subsection (a). The Director shall 
disseminate to the States the findings made as a result of the 
evaluations.
    ``(k) Reports to Congress.--
            ``(1) Initial report.--Not later than October 1, 2005, the 
        Director shall submit to the Committee on the Judiciary of the 
        House of Representatives, and the Committee on the Judiciary of 
        the Senate, a report describing programs carried out pursuant 
        to this section.
            ``(2) Periodic reports.--Not less than biennially after the 
        date described in paragraph (1), the Director shall prepare a 
        report describing programs carried out pursuant to this section 
        during the preceding 2-year period, and shall submit the report 
        to the Administrator for inclusion in the biennial report under 
        section 501(k).
            ``(3) Summary.--Each report under this subsection shall 
        include a summary of any evaluations conducted under subsection 
        (j) during the period with respect to which the report is 
        prepared.
    ``(l) Definitions.--In this section:
            ``(1) Juvenile.--The term `juvenile' means anyone 18 years 
        of age or younger at the time of admission to a program 
        operated pursuant to subsection (a).
            ``(2) Treatment services.--The term `treatment services' 
        means treatment for substance abuse, including the counseling 
and services described in subsection (d)(3).

``SEC. 592. OUTPATIENT TREATMENT PROGRAMS FOR JUVENILES.

    ``(a) Grants.--The Secretary, acting through the Director of the 
Center for Substance Abuse Treatment, shall make grants to eligible 
entities to establish projects for the outpatient treatment of 
substance abuse among juveniles.
    ``(b) Prevention.--Entities receiving grants under this section 
shall engage in activities to prevent substance abuse among juveniles.
    ``(c) Evaluation.--The Secretary shall evaluate projects carried 
out under subsection (a) and shall disseminate to appropriate public 
and private entities information on effective projects.

``SEC. 593. AUTHORIZATION OF APPROPRIATIONS.

    ``(a) In General.--There are authorized to be appropriated to carry 
out this part $100,000,000 for each of the fiscal years 2005 through 
2007.
    ``(b) Minimum Allocation.--Unless all eligible applications 
submitted by any State or unit of local government within such State 
for a grant under this part have been funded, such State, together with 
grantees within the State (other than Indian tribes), shall be 
allocated in each fiscal year under this section not less than 0.75 
percent of the total amount appropriated in the fiscal year for grants 
pursuant to this section.
    ``(c) Transfer.--In addition to the amounts authorized in 
subsection (a), there is authorized to be appropriated for the fiscal 
year from the special forfeiture fund of the Director of the Office of 
National Drug Control Policy such sums as may be necessary.
    ``(d) Rule of Construction.--The amounts authorized to be 
appropriated in this section are in addition to any other amounts that 
are authorized to be appropriated and are available for drug treatment 
programs for juveniles.''.

SEC. 704. DRUG TREATMENT ALTERNATIVE TO PRISON PROGRAMS ADMINISTERED BY 
              STATE OR LOCAL PROSECUTORS.

    (a) Prosecution Drug Treatment Alternative to Prison Programs.--
Title I of the Omnibus Crime Control and Safe Streets Act of 1968 (42 
U.S.C. 3711 et seq.) is amended by adding at the end the following new 
part:

  ``PART CC--PROSECUTION DRUG TREATMENT ALTERNATIVE TO PRISON PROGRAMS

``SEC. 2901. PILOT PROGRAM AUTHORIZED.

    ``(a) In General.--The Attorney General may make grants to State or 
local prosecutors for the purpose of developing, implementing, or 
expanding drug treatment alternative to prison programs that comply 
with the requirements of this part.
    ``(b) Use of Funds.--A State or local prosecutor who receives a 
grant under this part shall use amounts provided under the grant to 
develop, implement, or expand the drug treatment alternative to prison 
programs for which the grant was made, which may include payment of the 
following expenses:
            ``(1) Salaries, personnel costs, equipment costs, and other 
        costs directly related to the operation of the program, 
        including the enforcement unit.
            ``(2) Payments to licensed substance abuse treatment 
        providers for providing treatment to offenders participating in 
        the program for which the grant was made, including aftercare 
        supervision, vocational training, education, and job placement.
            ``(3) Payments to public and nonprofit private entities for 
        providing treatment to offenders participating in the program 
        for which the grant was made.
    ``(c) Federal Share.--The Federal share of a grant under this part 
shall not exceed 75 percent of the cost of the program.
    ``(d) Supplement and Not Supplant.--Grant amounts received under 
this part shall be used to supplement, and not supplant, non-Federal 
funds that would otherwise be available for activities funded under 
this part.

``SEC. 2902. PROGRAM REQUIREMENTS.

    ``A drug treatment alternative to prison program with respect to 
which a grant is made under this part shall comply with the following 
requirements:
            ``(1) A State or local prosecutor shall administer the 
        program.
            ``(2) An eligible offender may participate in the program 
        only with the consent of the State or local prosecutor.
            ``(3) Each eligible offender who participates in the 
        program shall, as an alternative to incarceration, be sentenced 
        to or placed with a long term, drug free residential substance 
        abuse treatment provider that is licensed under State or local 
        law.
            ``(4) Each eligible offender who participates in the 
        program shall serve a sentence of imprisonment with respect to 
        the underlying crime if that offender does not successfully 
        complete treatment with the residential substance abuse 
        provider.
            ``(5) Each residential substance abuse provider treating an 
        offender under the program shall--
                    ``(A) make periodic reports of the progress of 
                treatment of that offender to the State or local 
                prosecutor carrying out the program and to the 
                appropriate court in which the defendant was convicted; 
                and
                    ``(B) notify that prosecutor and that court if that 
                offender absconds from the facility of the treatment 
                provider or otherwise violates the terms and conditions 
                of the program.
            ``(6) The program shall have an enforcement unit comprised 
        of law enforcement officers under the supervision of the State 
        or local prosecutor carrying out the program, the duties of 
        which shall include verifying an offender's addresses and other 
        contacts, and, if necessary, locating, apprehending, and 
        arresting an offender who has absconded from the facility of a 
        residential substance abuse treatment provider or otherwise 
        violated the terms and conditions of the program, and returning 
        such offender to court for sentence on the underlying crime.

``SEC. 2903. APPLICATIONS.

    ``(a) In General.--To request a grant under this part, a State or 
local prosecutor shall submit an application to the Attorney General in 
such form and containing such information as the Attorney General may 
reasonably require.
    ``(b) Certifications.--Each such application shall contain the 
certification of the State or local prosecutor that the program for 
which the grant is requested shall meet each of the requirements of 
this part.

``SEC. 2904. GEOGRAPHIC DISTRIBUTION.

    ``The Attorney General shall ensure that, to the extent 
practicable, the distribution of grant awards is equitable and includes 
State or local prosecutors--
            ``(1) in each State; and
            ``(2) in rural, suburban, and urban jurisdictions.

``SEC. 2905. REPORTS AND EVALUATIONS.

    ``For each fiscal year, each recipient of a grant under this part 
during that fiscal year shall submit to the Attorney General a report 
regarding the effectiveness of activities carried out using that grant. 
Each report shall include an evaluation in such form and containing 
such information as the Attorney General may reasonably require. The 
Attorney General shall specify the dates on which such reports shall be 
submitted.

``SEC. 2906. DEFINITIONS.

    ``In this part:
            ``(1) The term `State or local prosecutor' means any 
        district attorney, State attorney general, county attorney, or 
        corporation counsel who has authority to prosecute criminal 
        offenses under State or local law.
            ``(2) The term `eligible offender' means an individual 
        who--
                    ``(A) has been convicted of, or pled guilty to, or 
                admitted guilt with respect to a crime for which a 
                sentence of imprisonment is required and has not 
                completed such sentence;
                    ``(B) has never been convicted of, or pled guilty 
                to, or admitted guilt with respect to, and is not 
                presently charged with, a felony crime of violence, a 
                major drug offense, including drug trafficking, or a 
                crime that is considered a violent felony under State 
                or local law; and
                    ``(C) has been found by a professional substance 
                abuse screener to be in need of substance abuse 
                treatment because that offender has a history of 
                substance abuse that is a significant contributing 
                factor to that offender's criminal conduct.
            ``(3) The term `felony crime of violence' has the meaning 
        given such term in section 924(c)(3) of title 18, United States 
        Code.
            ``(4) The term `major drug offense' has the meaning given 
        such term in section 36(a) of title 18, United States Code.''.
    (b) Authorization of Appropriations.--Section 1001(a) of title I of 
the Omnibus Crime Control and Safe Streets Act of 1968 (42 U.S.C. 
3793(a)) is amended by adding at the end the following new paragraph:
            ``(24) There are authorized to be appropriated to carry out 
        part CC $30,000,000 for each of fiscal years 2005 through 
        2007.''.

SEC. 705. FUNDING FOR RESIDENTIAL TREATMENT CENTERS FOR WOMEN AND 
              CHILDREN.

    (a) In General.--The Director of the Center for Substance Abuse 
Treatment shall provide awards of grants, cooperative agreement, or 
contracts to public and nonprofit private entities for the purpose of 
providing treatment facilities that--
            (1) provide residential treatment for methamphetamine, 
        heroin, and other drug addicted women with minor children; and
            (2) offer specialized treatment for methamphetamine-, 
        heroin-, and other drug-addicted mothers and allow the minor 
        children of those mothers to reside with them in the facility 
        or nearby while treatment is ongoing.
    (b) Minimum Qualifications for Receipt of Award.--With respect to 
the principal agency of the State involved that administers programs 
relating to substance abuse, the Director may make an award under 
subsection (a) to an applicant only if the agency has certified to the 
Director that--
            (1) the applicant has the capacity to carry out a program 
        described in subsection (a);
            (2) the plans of the applicant for such a program are 
        consistent with the policies of such agency regarding the 
        treatment of substance abuse; and
            (3) the applicant, or any entity through which the 
        applicant will provide authorized services, meets all 
        applicable State licensure or certification requirements 
        regarding the provision of the services involved.
    (c) Requirement of Matching Funds.--
            (1) In general.--With respect to the costs of the program 
        to be carried out by an applicant pursuant to subsection (a), a 
        funding agreement for an award under such subsection is that 
        the applicant will make available (directly or through 
        donations from public or private entities) non-Federal 
        contributions toward such costs in an amount that--
                    (A) for the first fiscal year for which the 
                applicant receives payments under an award under such 
                subsection, is not less than $1 for each $9 of Federal 
                funds provided in the award;
                    (B) for any second such fiscal year, is not less 
                than $1 for each $9 of Federal funds provided in the 
                award; and
                    (C) for any subsequent such fiscal year, is not 
                less than $1 for each $3 of Federal funds provided in 
                the award.
            (2) Determination of amount contributed.--Non-Federal 
        contributions required in paragraph (1) may be in cash or in 
        kind, fairly evaluated, including plant, equipment, or 
        services. Amounts provided by the Federal Government, or 
        services assisted or subsidized to any significant extent by 
        the Federal Government, may not be included in determining the 
        amount of such non-Federal contributions.
    (d) Reports to Director.--A funding agreement for an award under 
subsection (a) is that the applicant involved will submit to the 
Director a report--
            (1) describing the utilization and costs of services 
        provided under the award;
            (2) specifying the number of individuals served and the 
        type and costs of services provided; and
            (3) providing such other information as the Director 
        determines to be appropriate.
    (e) Requirement of Application.--The Director may make an award 
under subsection (a) only if an application for the award is submitted 
to the Director containing such agreements, and the application is in 
such form, is made in such manner, and contains such other agreements 
and such assurances and information as the Director determines to be 
necessary to carry out this section.
    (f) Priority.--In making grants under this section, the Director 
shall give priority to areas experiencing a high rate or rapid increase 
in drug abuse and addiction.
    (g) Equitable Allocation of Awards.--In making awards under 
subsection (a), the Director shall ensure that the awards are equitably 
allocated among the principal geographic regions of the United States, 
subject to the availability of qualified applicants for the awards.
    (h) Duration of Award.--The period during which payments are made 
to an entity from an award under subsection (a) may not exceed 5 years. 
The provision of such payments shall be subject to annual approval by 
the Director of the payments and subject to the availability of 
appropriations for the fiscal year involved to make the payments. This 
subsection may not be construed to establish a limitation on the number 
of awards under such subsection that may be made to an entity.
    (i) Evaluations; Dissemination of Findings.--The Director shall, 
directly or through contract, provide for the conduct of evaluations of 
programs carried out pursuant to subsection (a). The Director shall 
disseminate to the States the findings made as a result of the 
evaluations.
    (j) Minimum Allocation.--Unless all eligible applications submitted 
by any State or unit of local government within such State for a grant 
under this section have been funded, such State, together with grantees 
within the State (other than Indian tribes), shall be allocated in each 
fiscal year under this section not less than 0.75 percent of the total 
amount appropriated in the fiscal year for grants pursuant to this 
section.
    (k) Authorization of Appropriations.--There are authorized to be 
appropriated to carry out this section such sums as may be necessary 
for each of the fiscal years 2005, 2006, and 2007.

            TITLE VIII--ANABOLIC STEROID CONTROL ACT OF 2003

SEC. 801. SHORT TITLE.

    This title may be cited as the ``Anabolic Steroid Control Act of 
2003''.

SEC. 802. AMENDMENTS TO THE CONTROLLED SUBSTANCES ACT.

    (a) Definitions.--Section 102 of the Controlled Substances Act (21 
U.S.C. 802) is amended--
            (1) in paragraph (41)--
                    (A) by realigning the margin so as to align with 
                paragraph (40);
                    (B) by striking subparagraph (A) and inserting the 
                following:
    ``(A) The term `anabolic steroid' means any drug or hormonal 
substance, chemically and pharmacologically related to testosterone 
(other than estrogens, progestins, corticosteroids, and 
dehydroepiandrosterone), and includes--
            ``(i) androstanediol--
                    ``(I) 3b,17b-dihydroxy-5a-androstane; and
                    ``(II) 3a,17b-dihydroxy-5a-androstane;
            ``(ii) androstanedione (5a-androstan-3,17-dione);
            ``(iii) androstenediol--
                    ``(I) 1-androstenediol (3b,17b-dihydroxy-5a-
                androst-1-ene);
                    ``(II) 1-androstenediol (3a,17b-dihydroxy-5a-
                androst-1-ene);
                    ``(III) 4-androstenediol (3b,17b-dihydroxy-androst-
                4-ene); and
                    ``(IV) 5-androstenediol (3b,17b-dihydroxy-androst-
                5-ene);
            ``(iv) androstenedione--
                    ``(I) 1-androstenedione ([5a]-androst-1-en-3,17-
                dione);
                    ``(II) 4-androstenedione (androst-4-en-3,17-dione); 
                and
                    ``(III) 5-androstenedione (androst-5-en-3,17-
                dione);
            ``(v) bolasterone (7a,17a-dimethyl-17b-hydroxyandrost-4-en-
        3-one);
            ``(vi) boldenone (17b-hydroxyandrost-1,4,-diene-3-one);
            ``(vii) calusterone (7b,17a-dimethyl-17b-hydroxyandrost-4-
        en-3-one);
            ``(viii) clostebol (4-chloro-17b-hydroxyandrost-4-en-3-
        one);
            ``(ix) dehydrochlormethyltestosterone (4-chloro-17b-
        hydroxy-17a-methyl-androst-1,4-dien-3-one);
            ``(x) 4-dihydrotestosterone (17b-hydroxy-androstan-3-one);
            ``(xi) drostanolone (17b-hydroxy-2a-methyl-5a-androstan-3-
        one);
            ``(xii) ethylestrenol (17a-ethyl-17b-hydroxyestr-4-ene);
            ``(xiii) fluoxymesterone (9-fluoro-17a-methyl-11b,17b-
        dihydroxyandrost-4-en-3-one);
            ``(xiv) formebolone (2-formyl-17a-methyl-11a,17b-
        dihydroxyandrost-1,4-dien-3-one);
            ``(xv) furazabol (17a-methyl-17b-hydroxyandrostano[2,3-c]-
        furazan);
            ``(xvi) 18a-homo-17b-hydroxyestr-4-en-3-one (13b-ethyl-17b-
        hydroxygon-4-en-3-one);
            ``(xvii) 4-hydroxytestosterone (4,17b-dihydroxy-androst-4-
        en-3-one);
            ``(xviii) 4-hydroxy-19-nortestosterone (4,17b-dihydroxy-
        estr-4-en-3-one);
            ``(xix) mestanolone (17a-methyl-17b-hydroxy-5a-androstan-3-
        one);
            ``(xx) mesterolone (1a-methyl-17b-hydroxy-[5a]-androstan-3-
        one);
            ``(xxi) methandienone (17a-methyl-17b-hydroxyandrost-1,4-
        dien-3-one);
            ``(xxii) methandriol (17a-methyl-3b,17b-dihydroxyandrost-5-
        ene);
            ``(xxiii) methenolone (1-methyl-17b-hydroxy-5a-androst-1-
        en-3-one);
            ``(xxiv) methyltestosterone (17a-methyl-17b-hydroxyandrost-
        4-en-3-one);
            ``(xxv) mibolerone (7a,17a-dimethyl-17b-hydroxyestr-4-en-3-
        one);
            ``(xxvi) nandrolone (17b-hydroxyestr-4-en-3-one);
            ``(xxvii) norandrostenediol--
                    ``(I) 19-nor-4-androstenediol (3b, 17b-
                dihydroxyestr-4-ene);
                    ``(II) 19-nor-4-androstenediol (3a, 17b-
                dihydroxyestr-4-ene);
                    ``(III) 19-nor-5-androstenediol (3b, 17b-
                dihydroxyestr-5-ene); and
                    ``(IV) 19-nor-5-androstenediol (3a, 17b-
                dihydroxyestr-5-ene);
            ``(xxviii) norandrostenedione--
                    ``(I) 19-nor-4-androstenedione (estr-4-en-3,17-
                dione); and
                    ``(II) 19-nor-5-androstenedione (estr-5-en-3,17-
                dione);
            ``(xxix) norbolethone (18a-homo-17b-hydroxypregna-4-en-3-
        one);
            ``(xxx) norclostebol (4-chloro-17b-hydroxyestr-4-en-3-one);
            ``(xxxi) norethandrolone (17a-ethyl-17b-hydroxyestr-4-en-3-
        one);
            ``(xxxii) oxandrolone (17a-methyl-17b-hydroxy-2-oxa-[5a]-
        androstan-3-one);
            ``(xxxiii) oxymesterone (17a-methyl-4,17b-dihydroxyandrost-
        4-en-3-one);
            ``(xxxiv) oxymetholone (17a-methyl-2-hydroxymethylene-17b-
        hydroxy-[5a]-androstan-3-one);
            ``(xxxv) stanozolol (17a-methyl-17b-hydroxy-[5a]-androst-2-
        eno[3,2-c]-pyrazole);
            ``(xxxvi) stenbolone (17b-hydroxy-2-methyl-[5a]-androst-1-
        en-3-one);
            ``(xxxvii) testolactone (13-hydroxy-3-oxo-13,17-
        secoandrosta-1,4-dien-17-oic acid lactone);
            ``(xxxviii) 1-testosterone (17b-Hydroxy-5a-androst-1-en-3-
        one);
            ``(xxxix) testosterone (17b-hydroxyandrost-4-en-3-one);
            ``(xl) tetrahydrogestrinone (13b,17a-diethyl-17b-
        hydroxygon-4,9,11-trien-3-one);
            ``(xli) trenbolone (17b-hydroxyestr-4,9,11-trien-3-one); 
        and
            ``(xlii) any salt, ester, or ether of a drug or substance 
        described in this paragraph; and
                    (C) by adding at the end the following:
    ``(C) Notwithstanding subparagraph (A), the Attorney General may 
not schedule Androstenedione as a controlled substance in accordance 
with this Act until the Attorney General receives a finding from the 
Commissioner of Food and Drugs relating to whether Androstenedione is 
lawfully marketed under the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 321 et seq.).''; and
            (2) in paragraph (44), by inserting ``anabolic steroids,'' 
        after ``marihuana,''.
    (b) Authority and Criteria for Classification.--Section 201(g) of 
the Controlled Substances Act (21 U.S.C. 811(g)) is amended--
            (1) in paragraph (1), by striking ``substance from a 
        schedule if such substance'' and inserting ``drug which 
        contains a controlled substance from the application of titles 
        II and III of the Comprehensive Drug Abuse Prevention and 
        Control Act (21 U.S.C. 802 et seq.) if such drug''; and
            (2) in paragraph (3), by adding at the end the following:
            ``(C) Upon the recommendation of the Secretary of Health 
        and Human Services, a compound, mixture, or preparation which 
        contains any anabolic steroid, which is intended for 
        administration to a human being or an animal, and which, 
        because of its concentration, preparation, formulation or 
        delivery system, does not present any significant potential for 
        abuse.''.
    (c) Anabolic Steroids Control Act.--Section 1903 of the Anabolic 
Steroids Control Act of 1990 (Public Law 101-647) is amended--
            (1) by striking subsection (a); and
            (2) by redesignating subsections (b) and (c) as subsections 
        (a) and (b), respectively.

SEC. 803. SENTENCING COMMISSION GUIDELINES.

    The United States Sentencing Commission shall--
            (1) review the Federal sentencing guidelines with respect 
        to offenses involving anabolic steroids;
            (2) consider amending the Federal sentencing guidelines to 
        provide for increased penalties with respect to offenses 
        involving anabolic steroids in a manner that reflects the 
        seriousness of such offenses and the need to deter anabolic 
        steroid use; and
            (3) take such other action that the Commission considers 
        necessary to carry out this section.

SEC. 804. PREVENTION AND EDUCATION PROGRAMS.

    (a) In General.--The Secretary of Health and Human Services 
(referred to in this Act as the ``Secretary'') shall award grants to 
public and nonprofit private entities to enable such entities to carry 
out science-based education programs in elementary and secondary 
schools to highlight the harmful effects of anabolic steroids.
    (b) Eligibility.--
            (1) Application.--To be eligible for grants under 
        subsection (a), an entity shall prepare and submit to the 
        Secretary an application at such time, in such manner, and 
        containing such information as the Secretary may require.
            (2) Preference.--In awarding grants under subsection (a), 
        the Secretary shall give preference to applicants that intend 
        to use grant funds to carry out programs based on--
                    (A) the Athletes Training and Learning to Avoid 
                Steroids program;
                    (B) the Athletes Targeting Healthy Exercise and 
                Nutrition Alternatives program; and
                    (C) other programs determined to be effective by 
                the National Institute on Drug Abuse.
    (c) Use of Funds.--Amounts received under a grant under subsection 
(a) shall be used primarily for education programs that will directly 
communicate with teachers, principals, coaches, as well as elementary 
and secondary school children concerning the harmful effects of 
anabolic steroids.
    (d) Authorization of Appropriations.--There is authorized to be 
appropriated to carry out this section, $15,000,000 for each of fiscal 
years 2004 through 2009.

SEC. 805. NATIONAL SURVEY ON DRUG USE AND HEALTH.

    (a) In General.--The Secretary of Health and Human Services shall 
ensure that the National Survey on Drug Use and Health includes 
questions concerning the use of anabolic steroids.
    (b) Authorization of Appropriations.--There is authorized to be 
appropriated to carry out this section, $1,000,000 for each of fiscal 
years 2004 through 2009.

             TITLE IX--NATIONAL GUARD COUNTER-DRUG SCHOOLS

SEC. 901. NATIONAL GUARD COUNTER-DRUG SCHOOLS.

    (a) Authority To Operate.--Under such regulations as the Secretary 
of Defense may prescribe, the Chief of the National Guard Bureau may 
establish and operate, or provide financial assistance to the States to 
establish and operate, not more than five schools (to be known 
generally as ``National Guard counter-drug schools'').
    (b) Purpose.--The purpose of the National Guard counter-drug 
schools shall be the provision by the National Guard of training in 
drug interdiction and counter-drug activities and drug demand reduction 
activities to personnel of the following:
            (1) Federal agencies.
            (2) State and local law enforcement agencies.
            (3) Community-based organizations engaged in such 
        activities.
            (4) Other non-Federal governmental and private entities and 
        organizations engaged in such activities.
    (c) Counter-drug Schools Specified.--The National Guard counter-
drug schools operated under the authority in subsection (a) are as 
follows:
            (1) The National Interagency Civil-Military Institute 
        (NICI), San Luis Obispo, California.
            (2) The Multi-Jurisdictional Counterdrug Task Force 
        Training (MCTFT), St. Petersburg, Florida.
            (3) The Midwest Counterdrug Training Center (MCTC), 
        Johnston, Iowa.
            (4) The Regional Counterdrug Training Academy (RCTA), 
        Meridian, Mississippi.
            (5) The Northeast Regional Counterdrug Training Center 
        (NCTC), Fort Indiantown Gap, Pennsylvania.
    (d) Use of National Guard Personnel.--(1) To the extent provided 
for in the State drug interdiction and counter-drug activities plan of 
a State in which a National Guard counter-drug school is located, 
personnel of the National Guard of that State who are ordered to 
perform full-time National Guard duty authorized under section 112(b) 
of that title 32, United States Code, may provide training referred to 
in subsection (b) at that school.
    (2) In this subsection, the term ``State drug interdiction and 
counter-drug activities plan'', in the case of a State, means the 
current plan submitted by the Governor of the State to the Secretary of 
Defense under section 112 of title 32, United States Code.
    (e) Treatment Under Authority To Provide Counter-Drug Support.--The 
provisions of section 1004 of the National Defense Authorization Act 
for Fiscal Year 1991 (Public Law 101-510; 10 U.S.C. 374 note) shall 
apply to any activities of a National Guard counter-drug school under 
this section that are for an agency referred to in subsection (a) of 
such section 1004 and for a purpose set forth in subsection (b) of such 
section 1004.
    (f) Annual Reports on Activities.--(1) Not later than February 1 
each year, the Secretary of Defense shall submit to Congress a report 
on the activities of the National Guard counter-drug schools during the 
preceding year.
    (2) Each report under paragraph (1) shall set forth the following:
            (A) The amount made available for each National Guard 
        counter-drug school during the fiscal year ending in the year 
        preceding the year in which such report is submitted.
            (B) A description of the activities of each National Guard 
        counter-drug school during the year preceding the year in which 
        such report is submitted.
    (g) Budget Matters.--The budget of the President that is submitted 
to Congress under section 1105 of title 31, United States Code, for any 
fiscal year after fiscal year 2004 shall set forth as a separate budget 
item the amount requested for such fiscal year for the National Guard 
counter-drug schools.
    (h) Authorization of Appropriations.--(1) There is hereby 
authorized to be appropriated for the Department of Defense for the 
National Guard for each of fiscal years 2004 through 2008, $30,000,000 
for purposes of the National Guard counter-drug schools in such fiscal 
year.
    (2) The amount authorized to be appropriated by paragraph (1) for a 
fiscal year is in addition to any other amount authorized to be 
appropriated for the Department of Defense for the National Guard for 
such fiscal year.

                   TITLE X--MISCELLANEOUS PROVISIONS

SEC. 1001. REPEALS.

    Sections 709, 710, and 711 are repealed.

SEC. 1002. AMENDMENT TO THE HIGHER EDUCATION ACT OF 1965.

    Section 484(r)(1) of the Higher Education Act of 1965 (20 U.S.C. 
1091(r)(1)) is amended by striking everything preceding the table and 
inserting the following:
            ``(1) In general.--A student who is convicted of any 
        offense under any Federal or State law involving the possession 
        or the sale of a controlled substance for conduct that occurred 
        during a period of enrollment for which the student was 
        receiving any grant, loan, or work assistance under this title 
        shall not be eligible to receive such grant, loan, or work 
        assistance from the date of conviction for the period of time 
        specified in the following table:''.

SEC. 1003. CONTROLLED SUBSTANCES ACT AMENDMENTS.

    (a) Technical Change.--Section 303(g)(2)(B) of the Controlled 
Substances Act (21 U.S.C. 823(g)(2)(B)) is amended by striking clause 
(iv).
    (b) Effective Data Provision.--Section 303(g)(2)(J)(ii) of the 
Controlled Substances Act (21 U.S.C. 823(g)(2)(J)(ii)) is amended by 
striking ``of the enactment of the Drug Addiction Treatment Act of 
2000'' and inserting in its place ``the drugs or combinations of drugs 
have, under the Federal Food, Drug and Cosmetics Act or section 351 of 
the Public Health Services Act, been approved for use in maintenance or 
detoxification treatment as required under paragraph (C)(i)''.

SEC. 1004. EXPORTATION OF NARCOTIC AND NONNARCOTIC DRUGS.

    Section 1003 of the Controlled Substance Import and Export Act (21 
U.S.C. 953) is amended--
            (1) in subsection (a), by striking paragraph (4) and 
        inserting the following:
            ``(4) substantial evidence is furnished to the Attorney 
        General by the exporter that the narcotic drug is to be applied 
        exclusively to medical, scientific, or other legitimate uses; 
        and''; and
            (2) in subsection (c), by striking paragraph (3) and 
        inserting the following:
            ``(3) substantial evidence is furnished to the Attorney 
        General by the exporter that the controlled substance is to be 
        applied exclusively to medical, scientific, or other legitimate 
        uses; and''.

SEC. 1005. STUDY OF WORK PLACE ENVIRONMENT AT ONDCP.

    Not later than 90 days after the date of enactment of this Act, the 
Comptroller General of the United States shall submit a report to 
Congress on the workplace environment at the Office of National Drug 
Control Policy, including an assessment of the turnover rate of 
employees and any sexual harassment or hostile work environment claims.

SEC. 1006. REQUIREMENT FOR LATIN AMERICAN HEROIN STRATEGY.

    (a) In General.--Not later than 90 days after the date of enactment 
of this Act, the Director of National Drug Control Policy shall submit 
to Congress a comprehensive strategy that addresses the increased 
threat from Latin American heroin, and in particular Colombian heroin.
    (b) Contents.--The strategy shall include a plan for--
            (1) opium eradication efforts to eliminate the problem at 
        the source to prevent it from reoccurring before the heroin 
        enters the stream of commerce;
            (2) interdiction and precursor chemical controls;
            (3) demand reduction and treatment;
            (4) provisions that ensure the maintenance at current 
        levels of efforts to eradicate coca in Colombia; and
            (5) assessment of the level of additional funding and 
        resources necessary to simultaneously address the threat from 
        Latin American heroin and the threat from Colombian coca.
                                 <all>